E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Viruses Events Announce Your Event Here

20–23 March 2019 29th Annual Meeting of the Society for Virology

the Heinrich-Heine-University in Düsseldorf

It is with great pleasure that we welcome you to the 29th Annual Meeting of the Society for Virology from 20–23 March 2019 at the Heinrich-Heine-University in Düsseldorf.

The annual meeting of the society covers a broad spectrum of topics in basic and clinical virology and attracts young scientists as well as experienced virologists. Keynote lectures by internationally recognized experts in viral immunology, molecular and clinical virology will complement the regular scientific workshops and poster sessions. A major aim of the meeting is to provide a platform for young scientist to present their work and ideas. Therefore, we welcome young researchers to join us and encourage all senior virologists to promote their mentees' attendance.

https://www.virology-meeting.de/

28–29 March 2019 3rd Annual Meeting of the European Virus Bioinformatics Center

Glasgow, UK

It is our pleasure to invite you to participate in the Third Annual Meeting of the European Virus Bioinformatics Center, to be held in Glasgow, UK, in March 2019. The meeting is jointly organized by the EVBC and the Centre For Virus Research.

The meeting will focus on bioinformatics approaches in virology, and we welcome any contributions within this cross-disciplinary field. Sub-topics include (but are not limited to): virus detection, annotation, and comparison; quasispecies, phylogeny, and cophylogeny; virus-host interaction and replication; as well as drug design.

Our aim is to bring together experts in virology and bioinformatics, to encourage and assist scientific exchange in both areas and initiate scientific cooperations. We look forward to welcoming old faces and new colleagues who share our excitement for computational virology!

We invite you to find more information on our website:

http://evbc.uni-jena.de/events/3rd-evbc-meeting/

3–5 June 2019 ScanVir2019 Meeting

Turku, Finland

It is our pleasure to announce that the first ScanVir Meeting will be held on June 3rd to 5th, 2019 in Turku, Finland. This meeting initiates a series of Scandinavian conferences, held every third year in one of the Scandinavian countries. The meeting will bring together Scandinavian and other international virologists, and creates opportunities for fruitful collaboration.

The topics include all aspects of virology and viral immunology - basic, applied and clinical virology. The program is divided into parallel sessions with plenary lectures given by distinguished keynote speakers. We will put extra effort in creating possibilities for stimulating cooperation by offering interactive sessions on the hot topics in virology and by providing the possibility of reserving "a think-tank room" for brainstorming sessions by small groups.

The meeting is committed to being "a green meeting": the venue, hotels and Turku city attractions, are all within walking distance and the venue providers and hotels are committed to taking responsibility for the environment. The sessions will be held on two locations conveniently connected by a pedestrian bridge over the river Aura and offering lovely views and short walking breaks between the sessions.

Information about the ScanVir2019 Meeting will constantly be updated on this webpage. Please share this message to anyone who might be interested in participating the meeting!

We warmly welcome you to the lovely summertime Turku in 2019!

Välkommen! Velkommen! Velkomin! Tervetuloa!

https://www.utu.fi/en/units/med/units/virology/scanvir2019/Pages/home.aspx

15–17 August 2019 The 11th International Retroviral Nucleocapsid and Assembly Symposium

Northeastern University, Boston, MA, USA

The goal of the meeting is to discuss retroviral replication and assembly, focusing on the roles of nucleocapsid and Gag proteins in these processes, as well as interactions with cellular factors. These interactions are addressed with a wide range of interdisciplinary methods, and the conference facilitates interactions between experts in a variety of methods, furthering research through networking and collaboration.

The primary topics covered in the meeting include:

Biophysical and structural studies
Gag, NC and RNA
Gag, NC, and membranes
Interactions with cellular factors
Immature virus assembly and budding
Therapeutic strategies

Please find more information on the website:

https://cos.northeastern.edu/irncas2019/

13–16 October 2019 31st International Workshop on Retroviral Pathogenesis

Padova, Italy

The International Workshop on Retroviral Pathogenesis (RetroPath), now in its 31st year, has long served as an active forum for the exchange of new research findings and concepts on all aspects of retroviral pathogenesis. RetroPath is the only meeting that brings diverse researchers, young and highly experienced, together to discuss on retroviruses infecting a wide variety of host species including birds, rodents, cats, ungulates and primates. It focuses on multiple aspects of retrovirus biology, starting with basic biology to pathogenic and oncogenic potential, endogenous retroviruses and their role in disease pathogenesis, host restriction factors, emerging retroviruses, vaccines, and gene therapy vectors.

Please find more information on the website:

https://www.discog.unipd.it/retropath2019

5–7 February 2020 Viruses 2020 - Novel Concepts in Virology

Barcelona, Spain

Dear Colleagues,

It is with great pleasure that we announce the conference Viruses 2020 - Novel Concepts in Virology to be held in Barcelona, Spain, 5-7 February 2020.

Because of their global impact on human, animal, and plant health and their utility as tractable model systems, viruses continue to play a central role in all aspects of biomedical research, ranging from molecular and cell biology, structural biology, and immunology to evolution, epidemiology, and bioinformatics. This conference will bring together leading virologists from around the world and across the broad field of virology to share results of their recent studies. Meeting participants will have the opportunity to present posters and short talks on their work and discuss their research in a stimulating and collegial environment.

The conference is sponsored by MDPI, the publisher of the open-access journal Viruses and follows the very successful meetings Viruses 2016 - At the Forefront of Virus-Host Interactions held in January 2016 in Basel, Switzerland and Viruses 2018 - Breakthroughs in Viral Replication, held in February 2018 in Barcelona.

We very much look forward to seeing you at this exciting meeting in Barcelona.

Dr. Eric O. Freed and Dr. Albert Bosch
Viruses 2020 Chairs

https://viruses2020.sciforum.net/

29–30 January 2019 Translating Phage-Based Applications into Clinically and Commercially Viable Therapeutics

Washington D.C, USA

With antimicrobial resistance a rising global crisis, western medicine’s interest is turning to phage therapy as an alternative to antibiotics. Challenging past uncertainty in phage therapy’s commercial viability, recent developments such as highly positive results of compassionate use cases in the US has excited the field and the next step is successful phase II clinical trials.

The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. The conference will cover key industry trends including:

  • Regulatory guidance to achieve clinical data from Cara Fiore, FDA
  • Strategies to access the market via the veterinary, personalize medicine and traditional pharmaceutical routes
  • Insights into investment drivers for phage therapy from NIH and Boehringer Ingelheim
  • Facts on how to manufacture GMP phage
  • Applications to overcome multi-drug resistance with combined approaches such as phage therapy and antibiotics

https://phage-futures.com/events/phage-futures-2019?afid=536&cpid=7759&utm_source=MDPI&utm_medium=Web%3A+Banner#agenda

28–30 November 2018 2nd National Congress of the Italian Society for Virology: One Virology One Health

Aula Magna, Sapienza Università di Roma, Rome

The National Congress of the Italian Society for Virology represents the annual forum for the Italian scientists working in the different areas of Virology (medical-clinical Virology, molecular Virology, veterinary Virology, environmental Virology) involving basic, clinical and translational research and taking advantage of the most advanced technological platforms. It will be accredited to the Italian Ministry of Health for CME Credits for the following professionals: Medical Doctor (all disciplines), Biologist, Biotechnologist, Medical laboratory technician, Veterinary, Pharmacist, Physicist and Chemist.

https://www.congressosiv-isv2018.it/

14 November 2018 Seventh Annual David Derse Memorial Lecture and Award – Charles R.M. Bangham, PhD: “The Human Leukemia Virus HTLV-1: Regulation of Latency, Clonality, and Oncogenesis”

Frederick, Maryland, USA

Dear Colleagues,

Please join us at the Seventh Annual David Derse Memorial Lecture and Award on November 14, 2018 at 1:30 pm in the NCI at Frederick Conference Center. The HIV Dynamics and Replication Program (HIV DRP) hosts this annual lecture and award series with support from Hye Kyung Chung-Derse and the National Cancer Institute to honor the outstanding research accomplishments of David Derse, PhD.

Dr. Derse was a Principal Investigator and Head of the Retrovirus Gene Expression Section in the HIV DRP. During his 25 years at the National Cancer Institute, he investigated the molecular mechanisms of retrovirus infection and replication, concentrating most recently on the human viruses HIV-1 and HTLV-1. In 2007, Dr. Derse and his research team discovered how HTLV-1 evades the body's natural defenses to fight off infection, a finding that may eventually lead to improved antiviral therapies and new strategies for preventing some types of cancer.

Charles R.M. Bangham, PhD (Imperial College London) will deliver the seventh lecture in this series. The title of his presentation is “The Human Leukemia Virus HTLV-1: Regulation of Latency, Clonality, and Oncogenesis.”

Additional details are provided below. Please note that if you cannot join us in person, a live-captioned videocast of the lecture and award presentation will be available on the NIH Videocast website at https://bit.ly/2EOum6n. This videocast will also be archived at the same site after November 14.

Best regards,
Eric O. Freed, PhD
Editor-in-Chief, Viruses
Director, HIV Dynamics and Replication Program
National Cancer Institute
Frederick, MD, USA

https://ncifrederick.cancer.gov/events/conferences/DavidDerseMemorialLecture

7 November 2018 International HBV Cure Workshop 2018

Toronto, Canada

We are proud to announce the 5th edition of the International HBV Cure Workshop 2018, which will take place on 7 November 2018 in Toronto, Canada.

More than 250 million people are chronically infected with hepatitis B (HBV) around the globe. The purpose of the program is to inform the participants about the developments in the possibilities to find a cure for HBV. The meeting will be highly interactive with input from experts out of the arena of basic, translational and clinical HBV research. The field of HBV treatment is undergoing major changes and is on the verge of a paradigm shift. The many new treatment options that are becoming available are providing great hopes for decreasing the burden of the disease, simplifying treatment and ultimately curing and eradicating HBV infection. In order to optimize curative treatment for HBV, outstanding speakers from around the globe will share the newest therapeutic options for viral hepatitis and experts will discuss the path forward to cure this deadly disease, leading to liver cirrhosis and liver cancer. Questions on which end points to use in therapeutic trials and how to combine different agents targeting the virus and/or immune system will be extensively discussed. This workshop also brings together global interdisciplinary experts to provide a framework for how academia and industry should could collaborate to achieve the goal of curing hepatitis B.

http://www.virology-education.com/event/upcoming/hbv-cure-workshop-2018/

22–23 October 2018 5th Annual Meeting of the Spanish Network of Bacteriophages and Transducer Elements (FAGOMA)

Alcalá de Henares, Madrid, Spain

Bacteriophage research has played a key role in the development of molecular biology and genetic engineering. Moreover, phages are an essential part of natural ecosystems by modulating bacterial populations. Last but not least, phage therapy is currently regarded as an interest alternative to the use of more traditional antimicrobials amidst the current antibiotic resistance crisis.

FAGOMA was created in 2011 with the aim of bringing together teams involved in studying all aspects of phage biology and applications. Since that time, our annual meeting has been the perfect setting for promoting collaborative work between delegates, while also providing a valuable opportunity to discuss the latest results and methodologies.

We are pleased to announce the upcoming 5th Annual Meeting of the Spanish Network of Bacteriophages and Transducer Elements (FAGOMA), which will be held 22-23 October 2018 in Alcalá de Henares, Madrid (Spain).

This year our keynote speakers will be:

  • Prof. Pascale Boulanger, Head of the Team Bacteriophage T5, Institute for Integrative Biology of the Cell, Univ. Paris-Sud, Orsay Cedex, France.
  • Prof. Rosa Aznar, Director of the Spanish Type Culture Collection, University of Valencia, Spain.

We invite you to find more information on our website:

http://wwwuser.cnb.csic.es/~fagoma/Fagoma_Site/Bienvenida.html

17 October 2018 The Establishment and Control of Viral Persistence

Frederick, MD, USA

Dear Colleagues:

I am pleased to announce that the HIV Dynamics and Replication Program Conference on "The Establishment and Control of Viral Persistence" will be held at the National Cancer Institute campus in Frederick, Maryland on October 17, 2018 from 1:00 to 5:45 p.m. The HIV Dynamics and Replication Program is hosting this half-day conference to showcase the latest findings in the broad field of viral persistence. A major barrier to the successful eradication of many viral infections, including HIV, herpes viruses, Ebola virus, and others, persistence is governed by a complex web of viral and cellular factors acting at the level of individuals and populations. An in-depth discussion of how viruses persist, while hosts resist, should lead to new strategies aimed at eliminating viruses entrenched in humans. Confirmed speakers in this outstanding program include Blossom Damania (University of North Carolina School of Medicine), John Mellors (University of Pittsburgh School of Medicine), Carla Saleh (Institut Pasteur), John Schiller (Laboratory of Cellular Oncology, National Cancer Institute), Guido Silvestri (Yerkes National Primate Research Center, Emory University School of Medicine), and Bill Sugden (McArdle Laboratory for Cancer Research, University of Wisconsin–Madison). There is no registration fee, but participants are encouraged to register (https://ncifrederick.cancer.gov/events/conferences/HIVDRPconference2018/registration) in advance, as seating is limited. A live-streamed and archived videocast of the conference will be available on the NIH Videocast website at https://videocast.nih.gov/summary.asp?live=28388&bhcp=1. I hope you will be able to join us on October 17!

Best regards,
Eric O. Freed, Ph.D.
Editor-in-Chief, Viruses
Director, HIV Dynamics and Replication Program
Center for Cancer Research
National Cancer Institute
Frederick, MD, USA

https://ncifrederick.cancer.gov/events/conferences/HIVDRPconference2018

24–25 September 2018 The 4th symposium of the French Phage Network

Bordeaux, France

We are pleased to announce the upcoming 4th Annual Symposium of the Network "Phages.fr", which will be held 24-25 September 2018 in Bordeaux,France. We invite you to find more information on our website.

http://phages.fr/

23–26 September 2018 21st ESCV Annual Meeting

Athens, Greece

It is our great pleasure to invite you to the 21st ESCV Annual Meeting which will be held in Athens, 23-26 September, 2018. The ESCV Annual Meeting has been a major event for the Clinical Virology scientific community and it is becoming more popular, comprehensive, innovative and influential, while maintaining high standards of scientific quality and a family atmosphere. The 21st ESCV Annual Meeting is promising to be an exciting event, covering all timely topics of Clinical Virology, enabling delegates to exchange knowledge with world’s leading experts, network with colleagues and discuss the latest advances on "traditional" and emerging viruses.

http://www.escv2018.com/

6–7 September 2018 2018 Chromatin Control of Viral Infection

Natcher Conference Center, National Institute of Health, Bethesda, Maryland

Like their cellular hosts, invading viral pathogens that depend upon the host cell nuclear machinery are also subject to the regulatory impacts of chromatin.

For lytic pathogens, successful infection depends upon the ability to counter cellular defense mechanisms that can result in suppressive heterochromatin assembled on the viral genome along with utilization of cellular chromatin modulation activities that promote efficient viral gene transcription and DNA replication. Additionally, viral pathogens whose complex replication cycles include coupled stages of lytic replication and latency/persistence are impacted by epigenetic modulation that plays a controlling role in determining the viral state.

Research into the basic biology of chromatin deposition, modification, and modulation/remodeling will contribute to the understanding of the complex host-viral interactions that influence the progression of viral diseases. Additionally, insights into the role of epigenetic machinery in controlling viral infection can present novel opportunities for prophylaxis or treatment. The workshop "2018 Chromatin Control of Viral Infection" will focus on epigenetic mechanisms that regulate viral chromatin states, viral encoded factors that modulate viral and/or cellular chromatin, and epigenetic control of host cell antiviral responses.

We invite you to participate in this intimate symposium-workshop.

Registration and additional information online at:

http://www.cvent.com/events/2018-chromatin-control-of-viral-infection/event-summary-90d681653526456f8bace9a8129390e1.aspx

30 August–2 September 2018 APCCMI cum IICC 2018

Hong Kong, China

APCCMI-IICC 2018 is an important meeting on clinical microbiology, infectious diseases diagnostics and management, infection prevention and control, which offers a unique opportunity for clinicians, scientists, researchers, pharmacists , infection control professionals / preventionist and other healthcare professionals to meet international experts from various parts of the world.
Visit the congress website for more information:

http://www.apccmi-iicc2018.hk/

30–31 August 2018 The 12th International Foamy Virus Meeting

Dresden, Germany

The International Foamy Virus Meetings are an important forum for participants from all over the world to discuss their latest results in the field of foamy viruses and related retroviruses and represents a valuable opportunity for networking and collaborating. We invite you to submit until June 15th high quality abstracts for oral presentations on the following scientific topics:

• Epidemiology of Natural and Zoonotic Infections
• Interaction of Foamy Viruses with the Immune System
• Molecular and Cellular Biology of the Foamy Virus Replication Strategy
• Mechanisms of Virus – Host Cell Interactions
• Structural Studies of Foamy Virus Proteins
• Development of Foamy Virus Gene Transfer and Genome Editing Tools
• Application of Foamy Virus Vectors for Gene Therapy Treatment Strategies

Our invited Keynote Speakers will be,
• Prof. Welkin Johnson, Chair Biology Department, Boston College, USA
• Prof. Frank Buchholz, Medical Systems Biology, University Cancer Center TU Dresden, Germany

The Institute of Virology at the Medical Faculty Carl Gustav Carus of the Technische Universität Dresden is very pleased to welcome you to the 12th International Foamy Virus Meeting from August 30th to 31st, 2018
Dresden, Germany.

Please find more information on our meeting website

https://tu-dresden.de/med/mf/virologie/foamyvirusmeeting2018?set_language=en

14–18 July 2018 The American Society for Virology Annual Meeting

University of Maryland, College Park, MD

The American Society for Virology is a 501(c)(3) nonprofit that promotes the exchange of information and stimulates discussion and collaboration among virologists. The purpose of the Society is the advancement and promulgation of knowledge relevant to virology.


For more information about the ASV Annual Meeting please visit

http://asv2018.umd.edu

9–13 July 2018 Viruses of Microbes V: Biodiversity and future applications

Wroclaw, Poland

The central theme of the meeting is ‘Biodiversity and future applications’ of viruses infecting microbes (algae, archaea, bacteria, fungi, protozoa and viruses). Viruses have always been a key element of microbial diversity and evolution, as well as a tool for a molecular biologist to learn more about how the host cell functions. This information has also been put to productive use in latter days to control infections and fouling in many areas of our modern life.
The conference talks are grouped into sessions covering key areas of ecology, host-virus dynamics, biotechnological, medical aspects, and structural biology. A main objective of the meeting is to stimulate new understanding of the role that viruses of microbes play in ecosystems and in the sustainable development of human technologies.

http://meetings.embo.org/event/18-virus-microbe

5–7 July 2018 Viroid-2018: International Conference on Viroids and Viroid-Like RNAs

Valencia, Spain

Viroids occupy the lowest step in the scale of life. Exclusively constituted by a relatively small molecule of non-coding circular RNA, viroids manage to replicate, move and avoid the defense response when entering the appropriate host plant, causing in many instances important diseases in agricultural crops. In Viroid-2018, the international conference on viroids and viroid-like RNAs that will be held in Valencia (Spain) from 5 to 7 July 2018, the community of viroid researchers will present and discuss recent discoveries about all aspects of viroid and viroid-like RNA biology, including viroid replication, traffic and interaction with the host plant; structure of viroid molecules and functional domains; viroid transmission, pathogenesis and disease control; viroid diagnosis and identification of new viroid species.

http://www.ibmcp.upv.es/viroid-2018/

22–24 June 2018 6th European Seminar in Virology (EuSeV) “Virus‐host interaction at single cell and organism level”

University of Bologna, Residential Center in Bertinoro, Italy

The “European Seminars in Virology” (EuSeV) are meant to be small, single-theme, highly attractive meetings for young European virologists, particularly PhD students and post-docs, in addition to senior virologists willing to participate. The talks are delivered by a selected group of Speakers. The topic of the EuSeV varies each time, and covers different aspects of basic, medical or clinical virology. The long term objective is to provide an instrument for doctoral and post-doctoral education and training, and to make a focus on key issues, thus implementing Virology in Europe.

For more information please visit:

http://www.eusv.eu/events/european-seminars-in-virology/

21–22 June 2018 EuroSciCon Conference on Virology

Paris, France

EuroSciCon Ltd. is proud to host the Conference on Virology (Virology-2018) taking place on June 21-22, 2018 Paris, France. The conference is themed around “From Viruses to Viromes” with the aim to bring together a wide audience of industry, healthcare, research, and medical practitioners to educate and bring about a fruitful debate on the confined topics. The Virology 2018 will be a great event to network, learn and engage with professionals in the field of infectious diseases, microbiology and virology.

For abstract submissions, please follow this link.
For conference details, please visit:

https://virology.euroscicon.com/

17–21 June 2018 Aquatic Virus Workshop 9

Lincoln, Nebraska, USA

We invite you to participate in the 9th International Aquatic Virus Workshop (AVW9) to be hosted and held at the University of Nebraska-Lincoln campus, June 17-21, 2018. The Workshop provides a forum for the discussion of viruses infecting microbes and protists of aquatic systems in all parts of the planet. Our intention is to promote discussion and collaboration among the world’s leading scientists in many dimensions of virology, including virus discovery and characterization, as well as the role of viruses in aquatic ecosystems functioning. The AVW9 will honor one of the founding members, James L. Van Etten of the University of Nebraska, for his significant contributions to algal virology.

http://avw2018.com/#notify

14–17 June 2018 The 2nd International Conference on Zika Virus and Aedes related Infections

Tallinn, Estonia

We are pleased to announce the Second International Conference on Zika Virus and Aedes Related Infections to take place in Tallinn, Estonia, June 14-17, 2018.

This unique, inter-disciplinary conference will include all Aedes related infections in addition to Zika. Aedes related infections have become a concern and continue to be a global threat with Europe being one of the affected areas. Recently Aedes related autochtonus infections of Chikungunya and Dengue have been increasingly reported. In addition, Zika virus is still circulating around the globe and continues to pose a scientific challenge with numerous unanswered aspects. The disease has an enormous impact on mothers, families, childbearing women and travelers. Despite many published papers there remain a lot of gaps, even though new information is constantly coming to light. The content of this conference will include: epidemiology and clinical aspects of Aedes related infections, gynecological aspects and follow up with children born to Zika infected mothers. In addition, virology aspects, diagnostic methods, new therapy and vaccine production as well as new methods of mosquito control all will be discussed in the meeting.

For further details please visit the conference website:

https://www.zikaconference2018.com/

13–15 June 2018 Canadian Society for Virology

Dalhousie University, Halifax, Nova Scotia, Canada

The 2nd Symposium of the newly-founded Canadian Society for Virology (CSV2018) will be held on Dalhousie's Carleton campus on June 13-15th, 2018. CSV2018 will unite basic, clinical, epidemiological and industrial virus researchers from across Canada, to discuss their research and foster exchanges and collaborative activities. We expect at least 150 attendees, and there will be a strong emphasis on enhanced training opportunities for students and fellows, including breakout sessions on STEM communication, career development, scientific publishing and ethics.

The symposium will feature the first CSV business meeting, which will inform future society activities. The meeting will also feature an excursion and banquet at the Halifax Citadel National Historic Site.
CSV2018 attendees will be invited to a Soapbox Science Event on June 16, to be held at the Halifax Seaport Farmer's Market, which will feature 12 female scientists, who will share their work with the general public.

https://www.fourwav.es/view/589/info/

10–14 June 2018 XVIIth International Parvovirus Workshop

Miami Beach, Florida, USA

We are delighted to organize the XVIIth International Workshop, which will be held from June 10th-14th, 2018 in Miami Beach, Florida, USA.

This meeting provides a unique opportunity for established and young basic scientists, clinicians, clinician-scientists, postdoctoral fellows, and graduate students, to interact with each other in an intimate setting since the total number of delegates is in the neighborhood of 120. In more recent years, there has been active participation from scientists from both small biotechnology companies as well as from big Pharma, focused on AAV vectors for human gene therapy.

For the 2018 meeting in Miami Beach, the following eminent parvovirologists have consented to deliver the Keynote Lectures:

Prof. Kenneth I. Berns, MD, PhD; University of Florida, USA
Prof. Nicholas Muzyczka, PhD; University of Florida, USA
Prof. Maria Söderlund-Venermo, PhD; University of Helsinki, Finland
Prof. Peter Tijssen, PhD; INRS-Institut Armand-Frappier, Université du Québec, Canada

For more information please visit:

http://parvovirusworkshop2018.org/

21–24 April 2018 28th European Congress of Clinical Microbiology and Infectious Diseases

Madrid, Spain

We invite you to the 28th European Congress of Clinical Microbiology and Infectious Diseases, which will take place in Madrid, Spain, from 21 - 24 April 2018.

The world’s leading experts will join the most important congress in infectious diseases, infection control and clinical microbiology to present and discuss the latest results. The Programme Committee is preparing a comprehensive scientific programme with keynote lectures, symposia, oral and poster sessions as well as educational formats on parallel tracks. We are looking forward to seeing you along with thousands of your colleagues from around the globe!

http://www.eccmid.org/

9–12 April 2018 6th Pan-American Dengue Research Network Meeting

Galveston, TX, USA

The Pan-American Dengue Research Network Meeting (http://www.pandenguenet.org/) is an initiative to gather researchers across the Americas every two years to discuss their recent advancements in the field, communicate this information to the scientific community in the region, foster collaborations among groups, and discuss future research strategies that will further strengthen the field. During these meetings, cutting-edge topics on dengue field are presented and discussed. One of the main objectives of this application is to guarantee the participation of many graduate students and junior investigators from Latin American and Caribbean regions, which have been usually underrepresented in science. The scientific meeting to be held for the first time in the US and undoubtedly will make an important contribution to supporting and broadening the impact of research on dengue throughout the hemisphere.

For more information, please visit our website http://www.pandenguenet.org/ and feel free to contact us at [email protected] if you have any questions.

http://www.pandenguenet.org/

9–10 April 2018 The Second Annual Meeting of the European Virus Bioinformatics Center

Utrecht, Netherlands

The Second Annual Meeting of the European Virus Bioinformatics Center will be held in Utrecht, The Netherlands on April 9-10, 2018.

The conference will broadly focus on computational approaches in virology, and we welcome any contributions within this cross-disciplinary field. Sub-topics include (but are not limited to): virus discovery, diagnostics, (meta-)genomics, modelling, molecular structure, evolution, and viral ecology. This meeting will bring together Virologists and Bioinformaticians from across the academic, industrial, professional and training sectors to share best practice.

We have invited a host of international speakers, and are very happy to present an exciting program. We have reserved a lot of time for discussion over posters in the program, so hereby we invite everyone (students, staff scientists, and speakers alike) to bring a poster along as a talking piece. Registration is free of charge, and works on a first-come, first-serve basis. The first 125 participants will be admitted, after which registration will be closed.

Please register via http://evbc.uni-jena.de/2nd-evbc-meeting/registration

http://evbc.uni-jena.de/2nd-evbc-meeting/

5–7 March 2018 8th Spring Meeting

Norfolk, Virginia, USA

Please join us at our 8th Spring Meeting which will be held March 5–7, 2018 in Norfolk, Virginia.

You’ll participate in the most exciting and challenging discussions on the industry’s most difficult applications including viral gene vectors and vaccines, adeno-associated virus (AAV), and other products derived with baculovirus technology, plus cellular therapies and three-dimensional, cellular structures. You can attend any talk you choose from the three concurrent programs, plus you’ll participate in a number of fun and stimulating networking events throughout the meeting that you can attend at no additional cost. This meeting offers unique opportunities to share technology with some of the most talented people in the biotech industry, plus key regulators and essential supply firms. For more information and to register, please visit

http://www.isbiotech.org

7–9 February 2018 Viruses 2018

Barcelona, Spain

Dear Colleagues,

It is with great pleasure that I announce the conference “Viruses 2018: Breakthroughs in Viral Replication” to be held in Barcelona, Spain 7-9, February, 2018. The importance of viruses to human health has never been more apparent, and significant progress is being made in understanding virus replication, structure, transmission, pathogenesis, and antiviral immunity. This conference will bring together leading virologists from around the world to share their recent findings. Meeting participants will have the opportunity to present posters and short talks on their work and discuss their research in a relaxed, collegial environment.

The conference is sponsored by MDPI, the publisher of the open-access journal Viruses and follows the very successful meeting Viruses 2016: At the Forefront of Virus-Host Interactions held in Jan 2016 in Basel, Switzerland. 

I very much look forward to seeing you at this exciting meeting in Barcelona.

Best regards,

Eric O. Freed, Ph.D.

Editor-in-Chief, Viruses
Director, HIV Dynamics and Replication Program
National Cancer Institute
Frederick, MD, USA

http://sciforum.net/conference/Viruses-2018

14 November 2017 Sixth Annual David Derse Memorial Lecture and Award -- Reuben S. Harris, PhD: “Viruses, APOBECs, and Human Diseases”

Frederick, Maryland, USA

Dear Colleagues,

Please join us at the Sixth Annual David Derse Memorial Lecture and Award on November 14, 2017 at 1:30 pm in the NCI at Frederick Conference Center. This event is sponsored by the HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute with support from Hye Kyung Chung-Derse, the National Cancer Institute, the Foundation for NIH, and colleagues and friends of Dr. Derse who contributed to the memorial fund in his honor.

We are hosting this annual lecture and award to honor Dave's outstanding research accomplishments and to stimulate the exchange of innovative ideas that he was well known for promoting throughout his scientific career. Reuben S. Harris, PhD (Howard Hughes Medical Institute and University of Minnesota) will deliver the sixth lecture in this annual series. The title of his presentation is “Viruses, APOBECs, and Human Diseases.”

Additional details are provided at https://home.ncifcrf.gov/hivdrp/news.html#Derse2017. Please note that if you cannot join us in person, the event will be videocast live at https://videocast.nih.gov/summary.asp?live=23625&bhcp=1 and an archived version of the captioned videocast will be available at this website after November 14.

Best regards,

Eric O. Freed, Ph.D.

Editor-in-Chief, Viruses
Director, HIV Dynamics and Replication Program
National Cancer Institute
Frederick, MD, USA

https://home.ncifcrf.gov/hivdrp/news.html#Derse2017

8–10 November 2017 16th Workshop "Cell Biology of Viral Infections" of the Society for Virology (GfV)

Schöntal (Germany)

The 16th Workshop on the Cell Biology of Viral Infections will bring four international renowned scientists (Professors Helenius, Kielian, Sodeik, and Pöhlmann) with unique experience in both cell biology and virology. The all four have investigated the virus life cycle during their entire career, specifically from cell biology perspectives.

This year, they will share their unique experience and vision with us in the great atmosphere of the Monastery of Schöntal (Germany).

For more information, please visit our website www.gfv-cellviro.de and feel free to contact us at [email protected] if you have any questions.

http://www.gfv-cellviro.de

18 October 2017 HIV Dynamics and Replication Program Conference on "Innate Immunity: Sensing, Signaling, and Selection"

Frederick, Maryland, USA

Dear Colleagues,

I am pleased to announce that the HIV Dynamics and Replication Program Conference on "Innate Immunity: Sensing, Signaling, and Selection" will be held at the National Cancer Institute campus in Frederick, Maryland on October 18, 2017 from 1:00 to 5:45 p.m.

The HIV Dynamics and Replication Program is hosting this half-day conference to showcase the latest findings in the broad field of innate immunity. The presentations will highlight recent advances in understanding cell-intrinsic immune strategies by which hosts counteract viral and bacterial infections and the mechanisms by which pathogens circumvent or overcome these immune barriers. Specific areas of focus will include immune sensing, mutational escape, paleovirology, interferon-induced effector specificity, inflammasomes, and evolutionary conflicts between pathogens and host restriction factors.  An in-depth discussion of recent progress in our understanding host-pathogen interactions within infected cells should lead to new insights into the roles that cellular factors play in preventing infections in uninfected cells, which will aid in the international public health efforts.

Invited speakers include Paul Bieniasz (Howard Hughes Medical Institute and Laboratory of Retrovirology, The Rockefeller University), Alex Compton (HIV Dynamics and Replication Program, National Cancer Institute), Carolyn Coyne (University of Pittsburgh School of Medicine), David Knipe (Harvard Medical School), Harmit Malik (Howard Hughes Medical Institute and Division of Basic Sciences, Fred Hutchinson Cancer Research Center), and Nan Yan (University of Texas Southwestern Medical Center).

There is no registration fee, but participants are encouraged to register in advance, as seating is limited.  A captioned live-streaming and archived videocast of the conference will be available on the NIH Videocast website at https://videocast.nih.gov/summary.asp?live=24839&bhcp=1.

I hope you will be able to join us on October 18.

Best regards,

Eric O. Freed, Ph.D.

Editor-in-Chief, Viruses
Director, HIV Dynamics and Replication Program
National Cancer Institute
Frederick, MD, USA

https://ncifrederick.cancer.gov/Events/hivdrug2017/

22–24 September 2017 The 17th Annual Rocky Mountain Virology Club Meeting

CSU Mountain Campus in Pingree Park, Colorado, USA

The 2017 meeting will be held Friday-Sunday, September 22-24 at the CSU Mountain Campus (formerly named Pingree Park). This year’s keynote speaker is Richard J. Kuhn, Purdue University. Visit the 2017 Meeting link from above, or download the meeting announcement

http://www.rockymountainvirologyclub.org/2017_Meeting.html

7–8 September 2017 IMAV 2017

University of Glasgow

IMAV 2017, the 2nd International Meeting on Arboviruses and their Vectors, aims to bring together experts in the field and will appeal to scientists involved in arbovirus research and beyond, as key questions in arbovirus biology also apply to other pathogens, including tick-borne bacteria or parasites.

The IMAV 2017 meeting aims to provide a platform to showcase advancements in the field by world-leading experts; give researchers in the field the opportunity to present their findings to an international audience;  give scientists at all levels, from students to experts and leaders, an opportunity to get a broad, up-to-date overview of important developments and questions in the field; and allow extensive networking opportunities at a Focused Meeting which is unique in its field.

https://www.microbiologysociety.org/event/society-events-and-meetings/focused-meeting-2017-2nd-international-meeting-on-arboviruses-and-their-vectors-imav-2017.html

17–21 July 2017 IUMS 2017

Singapore

Organised by International Union of Microbiological Societies (IUMS) and hosted by Singapore Society for Microbiology and Biotechnology (SSMB); IUMS 2017 Singapore will be held from 17-21 July 2017 at the Sands Expo & Convention Centre, Marina Bay Sands, this triennial congress encompasses THREE international congress, namely: 

  • 15th International Congress of Bacteriology and Applied Microbiology 
  • 15th International Congress of Mycology and Eukaryotic Microbiology 
  • 17th International Congress of Virology

The congresses will deal with all aspects of Infectious Diseases and Microbiology and is a platform for the exchange of knowledge and opinions of professionals from academia, industry, government and for fostering international collaborations. IUMS 2017 Singapore will have more than 100 international speakers and expects 3,000 attendees globally. With 28 plenary sessions/lectures, and over 80 workshops, we hope to engage and reach out to more audiences for this great opportunity where they can network, exchange ideas and learn some of the latest research or findings in the microbiological community - making this the world largest microbiology conference with the most comprehensive group of scientists at a single gathering with participation from across the globe

Join us in IUMS 2017, for an enlightening, informative and enriching experience.

For more information on IUMS 2017 Singapore, please visit: www.iums2017singapore.com

www.iums2017singapore.com

17–22 July 2017 DNATV 2017

Birmingham, UK

DNA Tumour Virus (DNATV) brings together a diverse group of researchers with common research interests in the study of DNA tumour viruses.

These viruses include the polyomaviruses, papillomaviruses, adenoviruses, herpesvirus and other DNA viruses. These viruses have served as invaluable models towards understanding the process of cancer progression. In some cases the DNA tumour viruses are also clinically important pathogens that cause cancer in humans. The most notable examples are the human papillomavirus that are the cause of essentially all cervical cancers. Research of HPV and other DNA tumour viruses continues to progress rapidly and this meeting is a major forum for the dissemination of these findings. The DNATV meeting has occurred yearly for over 4 decades and over the years has showcased extraordinary breakthroughs in virology and cancer biology. 

Join us in Birmingham, UK, 17th-22nd July 2017.

 

http://www.birmingham.ac.uk/facilities/mds-cpd/conferences/dnatv-2017/index.aspx

24–28 June 2017 ASV 2017

Madison, Wisconsin, USA

ASV President, Rebecca Dutch, the Officers, Councilors, Committee Members, and the local organizing committee headed by Kristen Bernard and Paul Friesen of the University of Wisconsin-Madison, invite you to participate in the 36th Annual Meeting of the American Society for Virology being held at the beautiful Monona Terrace Convention Center in Madison, Wisconsin.
The 2017 ASV scientific program will include symposia, five (5) satellite symposia; concurrent workshops and poster sessions on a wide range of virology topics; and special educational presentations punctuated by collegial mixers and social events and a showcase of exhibitors. The meeting begins Saturday morning, June 24th at 8:30 a.m. with the five satellite symposia and kicks off with the Welcome Reception at 3:30 pm. The Keynote Address will be presented from 5:30 to 6:30 pm and the first group of simultaneous workshop sessions will follow beginning at 7:00 pm. Note: The deadline for submission of abstracts is 11:59 p.m. EST on February 1, 2017.


Madison and the University of Wisconsin
Madison, with its four picturesque lakes in southern Wisconsin, offers and excellent range of cultural and recreational opportunities. The Monona Terrace Convention Center is located on the shores of Lake Monona, two blocks from the State Capitol and downtown attractions (museums, shopping and brewpubs). This amazing, multi-level structure designed by Frank Lloyd Wright is an architectural gem, and providing for the entire scientific program sessions, dining and the banquet to take place in this single, convenient location.


Registration Deadlines
May 19, 2017 at 11:59 pm EST deadline for EARLY registration fees; May 20, 2017 – June 16, 2017 registration fees increase for all registrants; June 17, 2017 through on-site a LATE REGISTRATION FEE ($75) is assessed for all registrations which may only be made on-site.


Accommodations
On-campus residence hall accommodations are available online through the conference website from January 3rd through June 1st. A number of rooms have also been blocked at local hotels. Visit the conference web site at https://extensionconferencecenters.uwex.edu/asv2017 for complete information; online meeting registration; as well as information on travel and lodging accommodations.


We look forward to seeing you at ASV 2017!

 

For further information contact:
Dorothea L. Sawicki, Ph.D., Secretary-Treasurer, ASV
Department of Medical Microbiology and Immunology
University of Toledo College of Medicine and Life Sciences
Tel. (419) 383-5173; Email: [email protected]

https://extensionconferencecenters.uwex.edu/asv2017

14–19 May 2017 GRC Viruses and Cells 2017

Renaissance Tuscany, Il Ciocco, Lucca (Barga), Italy

The 2017 Viruses and Cells GRC, the premier conference in the field of virology, will cover seminal topics in virology ranging from viral entry and structure to virus-host interactions, viral replication, immune responses to viral infection, and viral therapeutics.

The 2017 meeting will be held at Renaissance Tuscany, Il Ciocco, Lucca (Barga), Italy, from May 14-19, 2017. The conference is an interactive forum which brings together investigators at the forefront of the field, junior investigators launching their independent research careers, graduate students and postdoctoral fellows, and investigators from NIH and industry. The conference strives to represent a collegial environment that supports the discussion of novel ideas and fosters new collaborations.

Invited speakers will present novel and cutting edge findings in the field of virology. Topics will include: viral structure and entry, the immune response to viral infection, viral evasion of host immunity, viral replication and persistence, viral pathogenesis, virus-host interactions, modulation of cellular pathways by viruses, viruses and cancer, and viral therapeutics. Session chairs who are experts on the topic covered in each session will lead interactive, lively, and open discussions following each presentation.

In addition to each of the invited speakers, short talks will be chosen from the abstracts that are submitted to the meeting at the time of registration. Abstracts that highlight the most exciting and new developments in the field of virology will be selected for short talks, and the remainder of the abstracts will be selected as posters. The evening poster sessions are a prominent and important aspect of this conference providing yet another opportunity for participants to interact and discuss their research findings in an informal, friendly atmosphere.

Applications for this meeting must be submitted by April 16, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations

http://www.grc.org/programs.aspx?id=12500

24–26 April 2017 bacteriophage100

Paris, France

For one century bacteriophages, viruses of bacteria, have served and continue to serve as a basic model for understanding the fundamental principles of life. Indeed, research on bacteriophages is inseparable from the emergence of the field of molecular biology and led to major discoveries, from the identification of DNA as the genetic material and all the way to the discovery of the CRISPR-Cas systems which recently revolutionized many disciplines in life sciences. 

The year 2017 marks the 100th anniversary of the initiation of bacteriophage research by Félix d’Herelle at Institut Pasteur. To celebrate this occasion, Institut Pasteur, in collaboration with Eliava Institute, is organizing a special conference in its historic location – the “cradle” of bacteriophages. The event aims at providing a broad overview of the major milestones in the bacteriophage research and will cover recent advances in bacteriophage-host interactions, bacteriophage ecology, the evolutionary heritage of bacteriophages as well as their therapeutic, biotechnological and industrial applications.

This conference is endorsed by the International Society for Viruses of Microbes (www.isvm.org).

Next to this conference, on Thursday April 27 is organized the Human Phage Therapy Day.  The program of this event will be posted and diffused early March. Talks will be given by invited experts and allocated time will be devoted to exchanges around posters.

http://www.bacteriophage100.org/

8–10 November 2016 2nd ICGEB Workshop on Human papillomavirus: From Basic Biology to Cancer Prevention

Hong Kong

The workshop aims at providing a platform for sharing knowledge and research advances on human papillomavirus in relation to cancer development, detection, epidemiology & prevention. It will cover a wide range of topics including viral replication & life cycle, functions of oncoproteins, genome & RNA modification & regulation, HPV testing methodology & application, pathogenesis, epidemiology, cancer screening and public health issues. Areas related to cervical, anogenital, oropharyngeal and other cancers possibly associated with HPV are within the scope of this workshop.

Participants
- Researchers in the field of tumor virology, especially those focusing on HPV.
- Healthcare providers & administrators who may come across clinical problems related to HPV-associated cancers, especially cervical, anogenital and head & neck cancers.
- Healthcare professionals who may be involved in provision, interpretation or organizing cervical cancer screening programmes.
- Any scientists or clinicians who are interested in updating their knowledge on HPV and HPV-associated cancers.

Workshop Venue
Kai Chong Tong, G/F, School of Public Health Building,
Prince of Wales Hospital,
Shatin, Hong Kong

Important dates
Early Registration: 1 March – 15 September 2016
Standard Registration: 16 September – 15 October 2016
Abstract submission: 1 March – 30 June 2016

http://www.cuhk.edu.hk/med/mic/Events/ICGEB/index.html

24–26 October 2016 IV International Clinical Virology Symposium and Advances in Vaccines

Buenos Aires, Argentina

The Chairman and the Latin American correspondent from the Pan American Society for Clinical Virology (PASCV, US), are pleased to invite you to participate at the “IV International Clinical Virology Symposium and Advances in Vaccines” to be held in Buenos Aires, Argentina October 24-26 , 2016.

The main goals for this meeting are to share and discuss knowledge about the advances in viral diagnosis with a main focus in molecular assays and novel technologies, as well as to learn on the improvement, characteristics, and indications of new human vaccines and new therapeutics.    

This International Symposium is a great opportunity to gather together colleagues and friends from different countries, exchange knowledge about the recent advances of the most important and frequent issues in Clinical and Diagnostic Virology and advances of new Vaccines.  

http://www.virology2016.com/

19–22 October 2016 ECV 2016

Hamburg, Germany

It is my great pleasure to invite you to the 6th European Congress of Virology (ECV) which will take place from October 19-22, 2016 at the Congress Center Hamburg (CCH), Germany.

The European Congress of Virology is the premier virology conference in Europe and is organized by the European Society for Virology (ESV). ECV2016 will bring together both junior and senior scientists, and will cover all aspects of virus research including basic, clinical, veterinary and plant virology.

The Free and Hanseatic City of Hamburg is Germany’s principal port and a centre of maritime and aviation industries, as well as a hub of commerce, media and science. Above all, Hamburg is a city of hospitality and openness, characterized by its extraordinary diversity and tolerance.

The venue of ECV2016, the Congress Center Hamburg (CCH), is located in the city centre, within easy reach of numerous hotels of all categories.

The science, the planned special events, and the city itself will make ECV2016 a highly stimulating and unforgettable international event that should not be missed!

http://www.eurovirology2016.eu/

19 October 2016 HIV Dynamics and Replication Program Conference on “Emerging Viruses: Origins, Biology, and Control of Transmission”

Frederick, MD, USA

Dear Colleagues:

We are pleased to announce that the HIV Dynamics and Replication Program Conference on “Emerging Viruses: Origins, Biology, and Control of Transmission” will be held on October 19, 2016, from 1:00 to 5:45 pm at the National Cancer Institute (NCI) campus in Frederick, Maryland.

The HIV Dynamics and Replication Program is organizing this half-day conference to showcase the latest findings on emerging viral pathogens.  The presentations will focus on recent advances in: identifying the origins of virus emergence; understanding the molecular and immunological mechanisms by which viruses cross between species and establish new host ranges; developing vaccines and antiviral therapies against emerging viruses; and attenuating the geographic and ecological sources of vulnerability to disease transmission by emerging viruses.  An in-depth discussion of this recent progress will lead to new insights into the mechanisms involved in viral evolution and pathogenesis, which will aid in the international effort to control emerging viruses and mitigate their effects on public health.

Invited speakers in the outstanding program include: Sina Bavari, U.S. Army Medical Research Institute of Infectious Diseases; Christopher Buck, Laboratory of Cellular Oncology, National Cancer Institute; Adolfo Garcia-Sastre, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai; Andrew Haddow, U.S. Army Medical Research Institute of Infectious Diseases; W. Ian Lipkin, Center for Infection and Immunity, Mailman School of Public Health, Columbia University; and Michael Worobey, Department of Ecology and Evolutionary Biology, University of Arizona.

The agenda is available on the conference website at:
https://ncifrederick.cancer.gov/Events/hivdrug2016/agenda.asp

There is no registration fee, but participants are encouraged to register in advance, as seating is limited.  Online registration can be found at:
https://ncifrederick.cancer.gov/Events/hivdrug2016/register.asp

Please mark this event on your calendar and forward the announcement to colleagues who may be interested in attending this conference. You can also download a copy of the conference flyer at:
http://home.ncifcrf.gov/hivdrp/HIVDynamicsandReplicationProgramConference19October2016.pdf.

Organizing Committee:
Eric O. Freed, Ph.D.
John M. Coffin, Ph.D.
Wei-Shau Hu, Ph.D.
Stephen H. Hughes, Ph.D.
Mary Kearney, Ph.D.
Frank Maldarelli, M.D., Ph.D.
Vinay K. Pathak, Ph.D.
Alan Rein, Ph.D.

https://ncifrederick.cancer.gov/Events/hivdrug2016/

18–21 September 2016 IRNCAS -10th International Retroviral NucleoCapsid protein and Assembly Symposium

Montpellier, France

The topic of the IRNCAS International Symposium is the retroviral nucleocapsid protein (NC) and its Gag precursor, a polyprotein responsible for the viral assembly.

This symposium represents an important opportunity in getting together the specialists and generating new collaborations and multidisciplinary studies (biophysics, biochemistry, virology, cellular biology, biomedicine and biophotonics). During the last 15 years, these collaborations have provided important progresses in the insight into the molecular and cellular mechanisms of action of the HIV-1 nucleocapsid and its Gag precursor, making them promising targets in the design of inhibitors against the AIDS epidemics.

This 10th edition should encourage the continuation of our collaborative network in order to enlighten the structural and functional properties of the NC domain of Gag during virus assembly in the host cell.
Special attention will be given to :
- RNA-NC interactions
- Gag and cell factors interactions (membrane lipids and cellular proteins)
- Gag and NC chaperone properties
- The impact of the biophysical methods, notably of the high resolution microscopy and the NMR, on the understanding of Gag assembly
- Therapeutic strategies targeting HIV-1 NC and Gag assembly.

The major topics discussed during this Symposium are focused on the HIV-1 nucleocapsid and on the retroviral Gag proteins, however other nucleocapsid of viruses causing human pathologies (HTLV, Hepatitis and Influenza) will be also considered.

Registration closure June 3rd

http://irncas2016.sciencesconf.org/

15–16 September 2016 CCVI

Bethesda, Maryland

Chromatin Control of Viral Infection

Natcher Conference Center
NIH, Bethesda, Maryland

Registration and additional information online at: https://www.blsmeetings.net/ViralChromatin2016/

Preliminary Program
David Knipe (Harvard Medical School); Thomas Kristie (National Institute of Allergy and Infectious Diseases); Alison McBride (National Institute of Allergy and Infectious Diseases); Paul Lieberman (The Wistar Institute); Jonathan Karn (Case Western Reserve University); Meghan Holdorf (Novartis Institutes for BioMedical Research); David Bloom (University of Florida College of Medicine); John Sinclair (University of Cambridge); Ileana Cristea (Princeton University); Alan Engelman (Dana-Farber Cancer Institute, Harvard Medical School); Paul Lehner (Institute for Medical Research, University of Cambridge); Cyprian Rossetto (University of Nevada); Todd Macfarlan (National Institute of Child Health and Development); Sharon Schlesinger (The Hebrew University of Jerusalem); Ivan D’Orso (University of Texas Southwestern Medical Center); Alexander Tarakhovsky (Rockefeller University)
The program will also include select presentations from submitted abstracts as well as poster presentations.

 

https://www.blsmeetings.net/ViralChromatin2016/

14–17 September 2016 ESCV 2016

Lisbon, Portugal

We are very pleased to invite you to the 19th Annual Meeting of the European Society for Clinical Virology, that will take place in Lisbon, Portugal, from 14 to 17 September 2016. This meeting will cover hot topics of clinical virology, maintaining the high scientific standards of previous meetings of this Society.

Early Registration: until 22 June 2016
Late Registration: From 22 June 2016
Deadline for abtract submission: 30th May 2016

http://www.escv2016.com/

18–22 July 2016 Viruses of Microbes 2016

Liverpool, UK

This EMBO Conference will consider the viruses and virus-like agents associated with a diverse set of microbes that inhabit environments ranging from marine ecosystems to infected human lungs.  The conference will focus on the impact these diverse viruses have upon their environment, whether that environment is the human body or a specific niche in the natural environment.  The emphasis of the meeting, therefore, will be, ‘Ecological and environmental approaches to studying viruses of microbes’.

This EMBO Conference will include keynote speakers who have pioneered novel approaches to the study of viruses in environmental systems with the view to forging greater synergy between environmental and bacteriophage communities. We believe that this will be of great interest to a wide-ranging audience, for example understanding what constrains and drives diversity will inform those interested in both the fundamental and applied aspects of virus exploitation.  Therefore, this meeting is a ‘viruses of microbes’ meeting with the ecology of those viruses at its heart.

http://events.embo.org/16-virus-microbe/

18–22 June 2016 ASV 2016

Virginia Tech, Blacksburg, Virginia

ASV President, Grant McFadden, the Officers, Councilors, Committee Members, and the local organizing committee, invite you to participate in the 35th Annual Meeting of the American Society for Virology being hosted at the beautiful campus of Virginia Tech, in Blacksburg, Virginia.

The 2016 ASV scientific program will include symposia, three (3) satellite symposia; concurrent workshops and poster sessions on a wide range of virology topics; and special educational presentations punctuated by collegial mixers and social events and a showcase of exhibitors. The meeting begins Saturday morning, June 18th with the three satellite symposia and kicks off with the Welcome Reception at 3:30 pm. A Keynote Address will be presented from 5:30 to 6:30 pm and the first group of simultaneous workshop sessions will follow beginning at 7:00 pm.
Note: The deadline for submission of abstracts ended February 1, 2016.

Registration Deadlines
May 20, 2016 at 11:59 pm EST deadline for EARLY registration fees;
May 21, 2016 – June 7, 2016 at 12:00 am EST registration fees increase for all registrants;
June 8, 2016 through on-site a LATE REGISTRATION FEE is assessed for all registrations.

Accommodations
On-campus residence hall accommodations are available for participants from June 17th through June 23rd. In addition, a number of rooms have been blocked at local hotels which may be reserved by ASV 2016 meeting participants. Visit the conference web site at http://asv2016.cpe.vt.edu for complete program information; online meeting registration; as well as information on travel and lodging accommodations.

We look forward to seeing you at ASV 2016!

http://asv2016.cpe.vt.edu/

19–22 May 2016 32nd Clinical Virology Symposium

Daytona Beach, Florida, USA

Join ASM from May 19 to 22 in 2016 for the 32nd Clinical Virology Symposium.

Stay up-to-date with the latest research on viral infections through focused plenary sessions as well as poster and case presentations. New next year: the Symposium will take place from Thursday through Sunday, and it will include increased networking opportunities for you to expand connections with fellow laboratorians, physicians, and biomedical researchers involved in patient care and public health.

http://www.clinicalvirologysymposium.org/

26–28 January 2016 Viruses 2016 - At the Forefront of Virus–Host Interactions

Pharmacenter, Basel, Switzerland

An international scientific conference sponsored by the journal Viruses under the patronage of the University of Basel.

http://sciforum.net/conference/viruses-2016

9–13 October 2015 22nd International Symposium on Hepatitis C Virus and Related Viruses

Strasbourg, France

Join us for this prestigious meeting that has become the premier venue for the presentation of breakthrough scientific discoveries in the field of Hepatitis C and related viruses including the hepatitis A virus and the hepatitis E virus.

The programme will contain several plenary lectures from renowned researchers in the field while we anticipate a great number of exceptional abstracts to be selected for oral and poster presentations.

http://www.hcv2015.org/

11–15 July 2015 ASV 2015

Ontario, Canada

The ASV 2015 program will include symposia, workshops and poster sessions, and special events on a wide range of topics in virology.

http://www.asv2015.uwo.ca/

13–16 June 2015 9th International Conference on Oncolytic Virus Therapeutics

Boston, MA, USA

On behalf of the Organizing Committee, it is our great pleasure to welcome you to the great city of Boston for the 9th International Conference on Oncolytic Virus Therapeutics! The conference will run from the evening of Saturday, June 13, 2015 until the evening of Tuesday, June 16, 2015 at the Boston Park Plaza Hotel.

http://ovcboston.com/

2–4 June 2015 Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench to Bedside

University of Texas at Austin

The programme will include sessions on:
  • Novel influenza targets: polymerase, nucleoprotein and NS1 inhibitors

  • New inhibitors of influenza NA and M2

  • Inhibitors of HA function: DAS-181; fusion inhibitors; broad spectrum MAbs and smaller molecules targeting the HA stem

  • Antivirals and antibody-based therapies against other seasonal and emerging respiratory viruses

  • Host cell targets and determinants of host susceptibility: factors involved in virus replication or mediating the inflammatory response

  • Combination therapies

  • Clinical endpoints and regulatory issues

http://www.isirv.org/site/index.php/antiviral-home

18–23 May 2015 Retroviruses

Cold Spring Harbor, USA

TOPICS:


Entry
Post-Entry / Integration
Reverse Transcription / Recombination
Viral RNA Synthesis & Trafficking
Assembly / Release
Viral Protein Structure
Pathogenesis /Animal Models
Dependency & Restriction Factors 
Viral Counterdefenses
Antivirals 
Endogenous Retroviruses & Evolutio

http://meetings.cshl.edu/meetings/2015/retro15.shtml

13–16 May 2015 22nd International HIV Dynamics & Evolution

Budapest, Hungary

This meeting series was designed to promote discussion between specialists in quantitative and computational approaches in two areas in the field of HIV where these are particularly important.

  1. Modelling of viral and cellular dynamics
  2. Viral evolution and population genetics

https://cme.ucsd.edu/hivdynamics/index.html

11–15 May 2015 28th International Conference on Antiviral Research

Rome, Italy

This interactive session will focus on microbicide product development. Betsy Herold will discuss pharmacokinetic and pharmacodynamic evaluations of products that prevent a broad spectrum of virus infections. Perception and acceptability issues will be summarized by Kate Morrow and Jacob Esteswill talk about the biology of primary HIV infection as evaluated in nonhuman primate models.Robert Buckheit will then describe the development of an in vitro virus sterilization assay to define the required dosing of microbicide products.

http://www.isar-icar.com/?page=28thagenda

29 March–3 April 2015 Viruses and Human Cancer (D2)

Big Sky Resort, Big Sky, Montana, USA

The objective of the symposium is to explore how advances in cancer biology can inform the understanding of virus-induced cancers, and how viruses continue to reveal fundamental principles in cancer.

http://www.keystonesymposia.org/index.cfm?e=Web.Meeting.Program&meetingid=1341&subTab=program

23–26 February 2015 Annual Conference on Retroviruses and Opportunistic Infections (CROI)

Seattle, Washington, USA

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

http://www.croiconference.org/

30 October–2 November 2014 The Third ASM Conference on Viral Manipulation of Nuclear Processes

Washington, DC, USA

This meeting will bring together researchers who study how viruses manipulate cellular processes for their own replication focusing on how viruses perturb nuclear functions. The scope will be broad and will embrace diverse virus families, including DNA viruses that replicate in the nucleus, such as Polyoma-,Papilloma-, Adeno- and Herpesviruses, extending to  HIV,  retroviruses and nuclear RNA viruses, like Influenza. Also included will be RNA viruses that replicate in the cytoplasm but exploit or hijack nuclear functions. Topics will include subversion of host transcriptional machinery; effects on host DNA repair pathways; epigenetic alterations; viral remodeling of the nucleus; viral induction of the stress response, immune evasion and innate antiviral defense, miRNA regulation; viral effects on the nuclear membrane, and viruses and cancer. The goal of the conference is to integrate discussions on how different viruses have developed strategies to target host nuclear functions.

http://conferences.asm.org/index.php/upcoming-conferences/3rd-asm-conference-on-viral-manipulation-of-nuclear-processes

23–26 October 2014 5th International Conference on Retroviral Integration

Asilomar Conference Grounds, Pacific Grove, CA, USA

The International Conference on Retroviral Integration aims to bring together researchers, basic scientists and clinicians to share information and latest advances on the integration of retroviral DNA into the chromosome of a susceptible host cell. It blends the fields of chemistry, biology and clinical research to translate basic research into the clinic.

http://www.cvent.com/events/5th-international-conference-on-retroviral-integration/event-summary-83ab9a3c9cb3456f8fb1b997f201bdb8.aspx

21 October 2014 HIV Drug Resistance Program Conference on “Virus Structure: Putting the Pieces Together”

Conference Center, Frederick, MD, USA

The HIV Drug Resistance Program is hosting this half-day conference to showcase the latest findings on the structural biology of viruses, with a particular emphasis on imaging macromolecular structures and deciphering how viral and host proteins interact to mediate pathogenesis. Exploring new technologies that enhance the sensitivity of imaging systems will provide valuable information about the structure and dynamics of macromolecular assemblies to aid the design of more effective antiviral therapies.

http://ncifrederick.cancer.gov/Events/hivdrug/

18–19 September 2014 Chromatin Control of Viral Infection Symposium

Maryland 20892

Text: Advances in understanding the basic biology of chromatin deposition, modification, and modulation/remodeling will contribute to the understanding of viral diseases and present novel opportunities for prophylaxis or treatment. The workshop "2014 Chromatin Control of Viral Infection" brings together leaders in this research area representing various viral families.

https://www.blsmeetings.net/viralChromatin2014/

7–11 September 2014 HCV 2014: 21st International Symposium on Hepatitis C Virus and Related Viruses

Banff, Canada

The HCV Symposium is the leading international meeting for scientists interested in the molecular virology, pathogenesis, prevention and treatment of Hepatitis C Virus (HCV) infections. The Symposium is an important platform for the presentation of new developments in the fight against Hepatitis C. The goals of the Symposium are to increase the scientific understanding of the virus, and to gain insights applicable to future efforts for controlling its spread.

http://www.hcv2014.org/

13–15 August 2014 11th Australasian Plant Virology Workshop

Bisbane

This is the 11th workshop in the series and will be held in Brisbane, located in subtropical south-east Queensland. In August, the days are mild and sunny and perfect for enjoying the wonderful outdoors, such as the sweeping beaches of Surfers Paradise, the World Heritage rainforest of Lamington National Park or the annual Humpback Whale migration at Hervey Bay. This workshop is timed to immediately precede the 29th International Horticultural Congress, which is also hosted by Brisbane. This is only the second time that this congress, attended by more than 2,000 delegates from around the world, has been held in the Southern Hemisphere. So please reserve the dates of 13-15 August 2014 to attend the Australasian Plant Virology Workshop. It promises to be a highlight of the plant pathology conference calendar.

http://www.appsnet.org/interest_groups/Virology_workshop/index.html

27 July–1 August 2014 International Union of Microbiological Societies

Montreal, Canada

We are pleased to announce that the Opening Scientific Lecture, scheduled on Sunday, July 27, 2014, will be delivered by Prof. Julian Davies from the Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia.

http://www.montrealiums2014.org/welcome_e.shtml

14–18 July 2014 Viruses of microbes: Structure and function, from molecules to communities

Zurich, Switzerland

Viruses of microbes are the largest biological entity on planet earth. Despite their omnipresence, many aspects of the biology of viruses of microorganisms, the interaction with their hosts, and their ecological impact are not well understood. Furthermore, these viruses offer a broad repertoire of tools which can be harnessed for a variety of applications in medicine, food safety, and biotechnology. The Viruses of Microbes Meeting aims to bring together researchers working on all aspects of these organisms, ranging from fundamental research on structure, genetics, and molecular mechanisms, to biotechnology and applications.

http://events.embo.org/14-virus-microbe/index.html

30 June–2 July 2014 Post-transcriptional Gene Expression Regulation in Plants 2014

Poznan, Poland

An international symposium of the Polish Society of Experimental Plant Biology.

The Organizing Committee is very pleased to invite you to participate in the next Post-transcriptional Gene Expression Regulation in Plants meeting which will be held in Poznan, Poland, in the Collegium Biologicum of Adam Mickiewicz University, Umultowska 89, 61-614 Poznan. The PGRP meeting 2014 will start on Monday June 30th at 8.00 am, and end on Wednesday July 2nd at 2 pm.

All aspects of post-transcriptional regulation of gene expression in plants will be covered.

Topics include:

  • Regulation of pre-mRNA processing
  • RNA turn-over and surveillance
  • Regulation of translation
  • Epigenetics
  • Long non-coding RNAs
  • Biogenesis and function of small RNAs
  • Regulation of plant development and stress responses at the level of RNA
  • Bioinformatic and computational tools to study RNA structure, evolution and function

http://pgrp2014.amu.edu.pl/

24–25 June 2014 10th International Foamy Virus Conference

National Veterinary Research Institute Pulawy, Poland

The series of foamy virus conferences is an important international forum devoted to all aspects of Foamy Virus research. Such meetings let the attendees exchange recent data and ideas as on all aspects of Foamy Viruses including foamy virus infections and zoonoses, molecular biology, vector development, and host - virus interactions and creates a great opportunity for discussion. Therefore the organizers would like to invite scientists interested in Foamy Virus research to join us in Pulawy and to actively participate in this meeting. We will try to provide a good atmosphere and conditions for an interesting and fruitful meeting.

http://www.piwet.pulawy.pl/ifvc/

21–25 June 2014 33rd Annual Meeting of the American Society for Virology

Fort Collins, Colorado, USA

Colorado State University, Fort Collins, Colorado
June 21 – 25, 2014

We invite you to participate in the 33rd Annual Meeting of the American Society for Virology being held in Fort Collins, Colorado and hosted by the Colorado State University.

The 2014 ASV scientific program will include symposia, two (2) satellite symposia; concurrent workshops and poster sessions on a wide range of virology topics; and special educational presentations punctuated by collegial mixers and social events. The conference will also feature a showcase of exhibitors. The meeting will begin Saturday, June 21st with satellite symposia and kicks off with the Welcome Reception at 3:30 pm which will be followed by the Keynote Address at 5:30 pm and the first group of simultaneous workshop sessions that evening. Note: The deadline for the electronic submission of abstracts ended February 3, 2014.

Fort Collins and the Colorado Front Range

The City is a vibrant community with a thriving art and music scene centered in its Old Town district, a short walk from campus, or use the city’s new MAX rapid transit line. An array of culinary options can be found in Old Town and many offer outdoor dining. We urge you to consider spending a few extra days pre- or post-ASV 2014 to take advantage of Colorado’s abundance of natural beauty and recreational activities near Fort Collins, such as walking the Poudre River Trail, mountain biking at Horsetooth Resevoir, fly-fishing and white water rafting on the Cache La Poudre or Big Thompson Rivers, or visiting the Rocky Mountain National Park about an hour drive away in Estes Park, one of America’s most beautiful natural areas. Fly into Denver International Airport, located approximately 60 miles from Fort Collins, where shuttle bus services or car rentals may be reserved for travel to the meeting site.

Accommodations

On-campus residence hall rooms are available for participants. In addition, a number of rooms have been blocked at local hotels which may be reserved by ASV 2014 meeting participants. Visit the conference web site at www.asv2014.com for complete program information; online meeting registration; as well as information on travel and accommodations.


We look forward to seeing you at ASV 2014!


For further information contact:
Dorothea L. Sawicki, Ph.D., Secretary-Treasurer
AMERICAN SOCIETY FOR VIROLOGY
Department of Medical Microbiology and Immunology
University of Toledo College of Medicine and Life Sciences
3000 Arlington Avenue, Mail Stop 1021, Toledo, OH 43614
Tel. (419) 383-5173(419) 383-5173; E-mail: [email protected]

http://www.asv2014.com/

8–10 June 2014 1st International Symposium on Stress-Associated RNA Granules in Human Disease and Viral Infection

Dalhousie University Halifax, Nova Scotia, Canada

Scientific Program

-RNA granule dynamics
-interactions with viruses/bacteria
-RNA granules in cancer
-therapeutic strategies

http://rnagranules2014.com/

9–10 May 2014 3rd ACHA Conference 2014

Beijing, China

Over the years, treating viral diseases has become more and more complex. This workshop aims at providing treating physicians with an overview of the latest data, presented from a clinical perspective, and how these data translate to clinical practice, illustrated by interactive case discussions with national and international experts.

http://www.virology-education.com/event/upcoming/3rd-acha-conference-2014/

7–10 May 2014 21st HIV Dynamics and Evolution

Tucson, Arizona

This meeting series was initiated to promote discussion between specialists in quantitative and computational approaches in two areas in the field of HIV where these are particularly important.

  1. Modelling of viral and cellular dynamics
  2. Viral evolution and population genetics

Conference sessions will be organized to accommodate the best submitted talks.  We welcome submissions on all topics on statistical, mathematical and computational approaches to analyzing HIV’s dynamics and evolution.

https://cme.ucsd.edu/hivdynamics/index.html

21–23 January 2014 1st ScienceOne International Conference on Virology (SICV)

Dubai

Leading international researchers have been invited as keynote speakers, together with virologists from the Arab World, to present their findings and initiate brainstorming discussions. All branches of virology, including: viral respiratory infections, zoonosis, viral oncogenesis, hepatitis viruses, HIV and AIDS, and the future of vaccines will be covered

http://thescienceone.com/menacv/

30 October–2 November 2013 Genome Informatics

Cold Spring Harbor, NY, USA

The next Cold Spring Harbor Laboratory conference on Genome Informatics will be held at Cold Spring Harbor, New York (this meeting has alternated with Hinxton meeting started under the joint auspices of CSHL and the Wellcome Trust). The meeting will begin on at 7.30pm on Wednesday, October 30, and finish with lunch on Saturday, November 2, 2013.

http://meetings.cshl.edu/meetings/2013/info13.shtml

7–10 October 2013 AIDS VACCINE 2013

Barcelona, Spain

Since the first conference, organized in Paris in 2000, the AIDS Vaccine conference has become one of the most important annual events for the exchange of scientific information relating to HIV vaccine research and development. Beginning in 2007, the annual conference is organized under the aegis of the Enterprise and contributes to the goals of the Enterprise by:

  1. Providing a venue for an international exchange of information in HIV vaccine research and development
  2. Cross-fertilizing scientific areas of research
  3. Increasing coordination and communication among international groups
  4. Monitoring progress in the field

http://www.vaccineenterprise.com/conference/2013/

2 October 2013 Pseudotype viruses: applications and troubleshooting

Stevenage, UK

Pseudotype viruses are rapidly establishing themselves as important research and diagnostic tools of basic and clinical scientists facilitating the detailed study of individual viral genes, host cell receptors and highly pathogenic viruses, circumventing the need for high-level biosafety containment.

http://www.regonline.co.uk/builder/site/Default.aspx?EventID=1138675

17–21 September 2013 Microbial Pathogenesis and Host Response

Cold Spring Harbor, NY, USA

We are pleased to host the ninth Cold Spring Harbor meeting on Microbial Pathogenesis and Host Response, which will begin at 7:00 pm on Tuesday, September 17, conclude Friday evening with a banquet and departures on Saturday morning, September 21, 2013. The meeting will focus on interdisciplinary approaches to study infectious disease in animal and plant hosts, integrating the disciplines of molecular microbiology, eukaryotic cell biology, immunology, and genomics. The meeting will provide an in depth focus on the approaches that are being used to elucidate the mechanisms of bacterial and fungal pathogenesis, and promote the application of these concepts to understanding the evolution of emerging diseases.

http://meetings.cshl.edu/meetings/host13.shtml

11–14 September 2013 5th European Congress of Virology 2013

Lyon Convention Centre, France

For more than a decade, Virology in Europe has increased in strength and coordination. This was initiated through the organization of a regular “European Congress of Virology” (ECV) and was reinforced by the foundation of the “European Society for Virology” (www.eusv.eu) in Rome, April 24, 2009.

http://www.eurovirology2013.eu/events.php?IDManif=695&IDModule=71&IDRub=332

30 August–7 September 2013 2013 Host-microbes interactions

Spetses, Greece

The EMBO | FEBS course on 'Host-Microbes Interactions' is a highly successful international Summer course gathering 80 students and 16 lecturers . It will cover topics ranging from microbial diversity, bacterial assemblies, metagenomics and RNA-mediated regulation, to cellular microbiology and innate immunity. It will include an EMBO Plenary Lecture on 'Pathogens and commensals at Mucosal Surfaces: from homeostasis to disease', a EMBO YIP Lecture on 'Specificity in the ubiquitin system: learning from bacterial effectors' as well as an EMBO Science Policy Lecture on 'Pathogens, vaccines and society'.

http://events.embo.org/13-host-microbe/

25–28 August 2013 9th International Retroviral Nucleocapsid Protein and Assembly Symposium

OMNI Mont-Royal Hotel Montréal, Canada

The conference has historically focused on the multiple roles of Nucleocapsid (NC) protein of retroviruses, which is involved in the synthesis, maintenance and integration of proviral DNA and in virus particle assembly. Its role as a chaperone protein is perhaps its most important function as it promotes reverse transcription and coats the retroviral genomic RNAs. In the context of Gag, NC promotes viral RNA assembly and dimerization and interacts with several host cell factors. It is therefore a prime target for anti-HIV-1 therapy.

http://www.ncsymposium2013.org/

22–27 July 2013 DNA Tumour Virus Meeting

University of Birmingham, UK

The DNA Tumour Virus Meeting is the primary international conference for scientists studying the molecular biology of adeno, polyoma, and papillomaviruses; all important human pathogens which are the cause of several human cancers. Furthermore, these DNA tumour viruses represent model systems for understanding many fundamental processes in mammalian cells. For example, it is through their study that the critical tumour suppressors p53 and pRb were first discovered.

http://www.birmingham.ac.uk/facilities/mds-cpd/conferences/dtv-2013/index.aspx

21–25 July 2013 FEMS Congress 2013

Leipzig, Germany

The 5th Congress of European Microbiologists (FEMS 2013) is an exciting forum that will address the many challenges facing key areas in microbiology. Topical coverage of medical microbiology including molecular approaches, as well as biodiversity, bioremediation, eukaryotic microbes, virology and other key disciplines will provide you with a comprehensive overview as to the current state of the field. Symposia and workshops lead by prominent scientists are part of a scientific program that will focus on a rich and diverse array of pertinent topics. Join thousands of colleagues from across Europe and around the world in Leipzig, Germany, July 21-25, 2013 and help advance the field of microbiology.

http://fems.kenes.com/

20–24 July 2013 ASV 2013

Penn State University, State College, Pennsylvania

The American Society for Virology (ASV) invites you to participate in its thirty-second annual meeting on the Penn State University Park campus in beautiful central Pennsylvania. The deadline for the electronic submission of abstracts will be February 1, 2013.

http://www.asv.org/index.html

20–24 July 2013 IHW 2013

Grand Rapids, Michigan, USA

38th annual International Herpesvirus Workshop
Saturday, July 20 - Wednesday, July 24, 2013
Grand Rapids, Michigan, USA

http://www.herpesvirusworkshop.com/2013/

20–24 July 2013 ASV 32nd Annual Meeting

Pennsylvania, USA

The American Society for Virology (ASV) invites you to participate in its 32nd annual meeting to be held July 20 through 24, 2013, on the Penn State University Park campus in beautiful central Pennsylvania. The 2013 ASV scientific program will include symposia and concurrent sessions on multiple aspects of virology.

http://www.outreach.psu.edu/virology

7–10 July 2013 ASM Adelaide 2013

Adelaide, Australia

The Australian Society for Microbiology Annual Scientific Meeting is Australia's largest and most prestigious microbiological conference, bringing together researchers, clinicians, and other industry professionals. ASM 2013 will showcase the importance of microbiology to our world through presentations delivered by national and international leaders in their disciplines.

www.theasm.org.au/meetings/asm-adelaide-2013/

17–20 June 2013 63rd Annual Conference of the Canadian Society of Microbiologists

Ottawa, Canada

The CSM 2013 Ottawa Conference local organizing committee would like to invite you to the 63rd Annual Conference of the Canadian Society of Microbiologists which will be held at Carleton University, Ottawa, ON, June 17 – 20, 2013.

http://www.csm-scm.org/english/conf_upcoming.asp

17–19 June 2013 CRISPR: evolution, mechanisms and infection

St Andrews, UK

The extreme evolutionary pressure exerted on cells by viruses, and vice versa, is a key driving force in evolution. Perhaps the most exciting development in this area in the past 10 years is the discovery of the CRISPR system for antiviral defence. These clusters of regularly interspaced palindromic repeats are genomically encoded by many prokaryotes and carry a record of past viral infections.

http://www.biochemistry.org/Conferences/AllConferences/tabid/379/View/Conference/MeetingNo/SA148/Default.aspx

16–21 June 2013 15th International Negative Strand Virus Meeting

Granada, Spain

NSV 2013 will review all recent developments in the basic research on negative strand viruses, including the following topics:

  • In and Out and Moving about
  • RNA synthesis and Gene expression
  • Anti viral Response
  • Structure and Function
  • Host-cell Interactions
  • Pathogenesis
  • Vaccines and Antivirals
  • Natural and Unnatural virus Evolution

http://www.nsvmeeting2013.com/

3–6 June 2013 World Biotechnology Congress 2013

Boston, MA, USA

This unique international conference provides a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. Many Nobel Laureates and many world renowned experts will participate at the conference.

The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include major research advances in biotechnology, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.

http://www.worldbiotechcongress.com/

25 May–1 June 2013 Molecular Approaches to Clinical Microbiology in Africa

Blantyre, Malawi

The wind of change is blowing through clinical microbiology, not just in Africa but across the globe. Genome-based techniques are revolutionising the routine practice of the identification and characterisation of pathogens, opening many new opportunities and challenges in all areas of clinical microbiology from routine diagnosis to basic research.

http://www.wellcome.ac.uk/Education-resources/Courses-and-conferences/Advanced-Courses-and-Scientific-Conferences/Advanced-Courses/WTX050986.htm

16–19 May 2013 ASMCUE: Blending Science and Education

Englewood, CO, USA

If you have never attended the ASM Conference for Undergraduate Educators, you are encouraged to review last year's final program, presentations and handouts. Over 300 microbiology and biology educators attend the annual conference.

http://www.asmcue.org/

15–17 May 2013 Applied Bioinformatics and Public Health Microbiology 2013

Cambridge, UK

The aim of this conference is to provide a multidisciplinary forum showcasing recent advances in sequencing and bioinformatics relevant to microbiology and virology, illustrating how these advances are being translated to meet the needs of public health.  The sessions will therefore include presentations of research describing the use of ‘second’- and ‘third’-generation sequencing technologies to understand microbial diversity and evolution, pathogenesis, virulence and host-pathogen interactions.

https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=313

12–18 May 2013 Molecular Basis of Bacterial Infection: Contemporary Research Approaches

Hinxton, Cambridge, UK

This course will introduce participants to concepts and techniques used in studies on the molecular basis of bacterial infection and their interaction with the host, with an emphasis on contemporary high-throughput approaches.Several themes will run throughout providing a framework for bench experiments, demonstrations, supporting lectures and discussion groups. Core themes will include tissue-based assays, reporters, tissue culture, and microscopy (fluorescent and scanning/transmission electron microscopy).

http://www.wellcome.ac.uk/Education-resources/Courses-and-conferences/Advanced-Courses-and-Scientific-Conferences/Advanced-Courses/WTX026211.htm

5–10 May 2013 Viruses & Cells

Renaissance Tuscany Il Ciocco Resort Lucca (Barga), Italy

The 2013 Viruses and Cells Gordon Research Conference, the premier conference in the field, will address key questions in virology: viral infectious cycles, virus/cell interactions, the host immune response and viral immune evasion, pathogenesis, and the development of antiviral therapeutics and vaccines. The meeting will be held at Il Ciocco, the beautiful GRC conference site in Barga, Italy, from May 5-10, 2013.

http://www.grc.org/programs.aspx?year=2013&program=viruses

7–8 March 2013 2nd International Symposium on Neglected Influenza Viruses

Dublin, Ireland

This 2nd International Symposium on Neglected Influenza Viruses will retain the format, and build on the success of the inaugural symposium held in Florida in 2010. This conference will explore the latest surveillance data, vaccination and control strategies, diagnostic techniques, experimental research data and epidemiological and economic impact studies relating to swine, equine, canine and other nonhuman/nonavian influenza viruses.

http://www.onehealthglobal.net/?p=1421

3–6 March 2013 20th Conference on Retroviruses and Oppoertunistic Infections

Atlanta, USA

The Conference on Retroviruses and Opportunistic Infections (CROI) is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic. Over 4,000 leading researchers and clinicians from around the world convene in a different location each year for the Conference.

http://retroconference.org/2013

25–27 February 2013 Biodefense and Emerging Diseases Research Meeting

Washington, DC

11th Biodefense and Emerging Diseases Research Meeting
February 25-27, 2013
Washington, DC

http://www.asm.org/index.php/meetings-calendar

14–17 February 2013 The 2nd Conference on Controversies in Vaccination in Adults (CoVAC)

Leonardo Royal Hotel Munich

Over the years, the field of Adult Vaccination has undergone enormous expansion in clinical and basic data, as well as that of field-related technology. With the problem of diseases reaching epidemiological dimensions, treatment possibilities have digressed diversely. This development has created a need for debates on the numerous controversial issues, and to attain clinical conclusions.

http://www.comtecmed.com/covac/2013/Default.aspx

10–15 February 2013 From Bench to Field

Galveston, TX, USA

The 2013 Gordon Conference on Tropical Infectious Diseases: from bench to field, will present cutting edge research on the most prevalent and medically important tropical infectious diseases (TIDs), with special emphasis on research areas that have made significant recent progress.

http://www.grc.org/programs.aspx?year=2013&program=tropical

10–15 February 2013 HIV Vaccines

Keystone Resort, Keystone, Colorado, USA

Sponsored by Gilead Sciences, Inc. Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation.

http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1223

20–25 January 2013 Physical Virology Ventura

Ventura, CA, USA

As physical manifestations - in size, structure, molecular composition, and function - of the boundary between chemistry and biology, viruses receive ever-increasing attention in fundamental science and applied technology. The Physical Virology GRC covers viruses as paradigms for nanoscale self-assembly, genomic packaging and delivery, materials development, and interactions among biological systems.

http://www.grc.org/programs.aspx?year=2013&program=physviro

19–20 January 2013 Physical Virology

Ventura, CA, USA

The Gordon Research Seminar on Physical Virology is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

http://www.grc.org/programs.aspx?year=2013&program=grs_physvi

22–23 December 2012 ICVID 2012 : International Conference on Virology and Infectious Diseases

Amari Watergate Bangkok, 847 Petchburi Road, Bangkok 10400, Thailand

The XXXIII. International Conference on Virology and Infectious Diseases aims to bring together academic scientists, leading engineers, industry researchers and scholar students to exchange and share their experiences and research results about all aspects of Virology and Infectious Diseases, and discuss the practical challenges encountered and the solutions adopted.

http://www.waset.org/conferences/2012/bangkok/icvid/index.php

4–7 December 2012 HIV DART 2012

Loews Coronado Bay, 4000 Loews Coronado Bay Road, San Diego, California, 92118, USA

Frontiers in Drug Development for Antiretroviral Therapies

The focus of HIV DART 2012 is to assemble clinicians, nurses, researchers and basic scientists together to advance our knowledge of the ongoing drug development processes in antiretroviral research.
This conference will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection.

http://www.informedhorizons.com/hivdart2012/index.html

26–28 November 2012 The 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care

The Mayflower Renaissance Hotel Washington, DC

The mission of the 2012 National Summit is to support improvement in viral hepatitis and HIV testing, prevention, and engagement in care in the United States. The nation’s public health scientific and community leadership will meet to discuss state-of-the-art mechanisms to support the President’s “National HIV/AIDS Strategy” (NHAS) and the HHS “Action Plan for the Prevention, Care and Treatment of Viral Hepatitis” (VHAP).

http://www.hivforum.org/index.php?option=com_content&task=view&id=650&Itemid=60

24–27 October 2012 30th Annual Symposium on Nonhuman Primate Models for AIDS

San Antonio, TX October 24- 27, 2012 at the Westin Riverwalk Hotel

The symposium will consist of five Scientific Sessions and a Poster Session. Each of the five scientific sessions will have a Chair and a Co-Chair, who will be responsible for introducing speakers and recognizing questioners at the end of each presentation. In addition, the Session Chairs have been asked to give 30-minute presentations, summarizing critical developments in that particular area of research and his/her own contributions.

http://www.regonline.com/builder/site/default.aspx?EventID=1076910

27–30 September 2012 8th Annual International Respiratory Syncytial Virus (RSV)

Hilton Santa Fe on the Historic Plaza

It is our pleasure to announce the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium, to be held in Santa Fe, New Mexico, USA, September 27-30, 2012.

An exciting scientific program is planned highlighting the advances in basic and translational investigations of RSV disease. The majority of speakers will be selected from the unsolicited abstracts of registrants, thus providing an opportunity for younger scientists to present new findings. The meeting will be held at the historic Santa Fe Hilton, located on the Plaza. Visit many cultural and historic attractions, as well as dining and shopping options, just a few steps from the hotel.

Please make plans now to attend the International RSV Symposium. Continue to check this web site for updated information.

We look forward to seeing you in Santa Fe, NM, USA.

http://www.rsv2012.org/TEMPHome.html

17–18 September 2012 Chromatin Control of Viral Infection

William H. Natcher Building—Natcher Conference Center, National Institutes of Health, 45 Center Drive, Building 45, Bethesda, Maryland 20892


The role of chromatin and epigenetic regulation in cellular transcription, replication, and development has been well recognized. However, it has only recently been appreciated that invading viral pathogens that depend upon cellular nuclear machinery are also subject to the regulatory impacts of chromatin.
For lytic pathogens, successful infection depends both upon the ability to counter cellular defense mechanisms, such as deposition of nucleosomes with repressive chromatin marks, as well as the ability to utilize cellular activities that install positive marks to promote the efficient utilization of cellular transcription and/or replication machinery. Additionally, viral pathogens whose complex replication cycles include coupled stages of lytic replication and latency/persistence are impacted by epigenetic regulation that plays a controlling role in determining the viral state.
Advances in understanding the basic biology of chromatin deposition, modification, and modulation/remodeling will contribute to the understanding of viral diseases and present novel opportunities for prophylaxis or treatment. The workshop "Chromatin Control of Viral Infection" brings together leaders in this research area, representing various viral families as well as select experts in general chromatin biology.

http://www.blsmeetings.net/ViralChromatin2012

11–13 September 2012 Influenza2012

St Hilda's College Oxford, Cowley Place, Oxford, OX4 1DY, England, UK

The Oxford influenza conference, Influenza 2012, will address most aspects of basic and applied research on zoonotic and human influenza viruses. The conference invites proposals for podium and poster presentation in the following general areas of avian and mammalian influenza:

  • Molecular virology and immunology
  • Antiviral drugs and vaccines
  • Virulence and pathogenecity
  • Epidemiology and evolution
  • Mathematical models
  • Surveillance and contingency strategies
  • Viral detection and identification technologies

http://lpmhealthcare.com/Influenza2012/InfluenzaHome.htm

20–22 August 2012 2nd World Congress on Virology

Embassy Suites Las Vegas , USA

2nd World Congress on Virology is expected to bring the elite class of virologists and potential vaccine developers to share their eminent thoughts and experiences. Be there to witness some of the breakthroughs in field of virology.

http://www.omicsonline.org/virology2012/

1–5 August 2012 International Congress on Oncogenic Herpesviruses and Associated Diseases

Philadelphia (USA)

At this Congress, we are bringing together scientists from closely-related research communities by combining two conferences - the Biennial Conference of the International Association for Research on Epstein-Barr Virus (EBV) and Associated Diseases, and the Annual International Workshop on Kaposi's Sarcoma Associated Herpesvirus (KSHV) and Related Agents.

We hope that this joint conference will promote scientific interactions, fostering new collaborations and innovative research into tumor-associated herpesviruses.

We look forward to welcoming you to Philadelphia!

Congress Co-Chairs

Paul Lieberman, Ph.D., The Wistar Institute 
Erle Robertson, Ph.D., Perelman School of Medicine at the University of Pennsylvania
Yan Yuan, Ph.D., University of Pennsylvania School of Dental Medicine

http://www.penncancer.org/ICOHAD2012/

22–27 July 2012 XIX International Aids Conference

Washington D.C., USA

Dear Colleagues,

The return of the International AIDS Conference to the United States in July 2012 represents a significant victory for public health and human rights. The selection of Washington, DC as the site for the XIX International AIDS Conference (AIDS 2012) is the result of years of dedicated advocacy to end the nation’s misguided entry restrictions on people living with HIV – restrictions that were based on fear, rather than science.
The biennial International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policymakers, people living with HIV and others committed to ending the epidemic. It will be a tremendous opportunity for researchers from around the world to share the latest scientific advances in the field, learn from one another’s expertise, and develop strategies for advancing all facets of our collective efforts to treat and prevent HIV.
AIDS 2012 is expected to convene more than 25,000 delegates from nearly 200 countries, including more than 2,500 journalists. The conference will be held from 22 to 27 July 2012 at the Walter E. Washington Convention Center. The International AIDS Society, the world's leading independent association of HIV professionals, with 14,000 members in 190 countries, will organize AIDS 2012 in collaboration with our international and local partners.
We are gratified by the enthusiastic support expressed by our U.S. government and civil society partners for holding AIDS 2012 in Washington, DC. The world’s leading AIDS experts will gather for AIDS 2012 in a community deeply impacted by the epidemic, providing a tremendous opportunity for partnership and exchange that will further sow the seeds of solidarity among all of us dedicated to ending this scourge. The selection of Washington, DC, as the AIDS 2012 venue is also significant as it is home to key players in the global response to AIDS, including the Office of the U.S. Global AIDS Coordinator (which directs PEPFAR – President’s Emergency Plan for AIDS Relief), the National Institutes of Health and the World Bank.

AIDS 2012 will play a key role in shaping international responses to this devastating epidemic. As with all our conferences, we will work with partners to make sure that the conference has a deep and lasting impact in our host city and country. We look forward to partnering with the residents of Washington, DC, and with other groups across the U.S. to ensure the conference further strengthens the U.S. role in global AIDS initiatives, re-energizes the response to the U.S. domestic epidemic, and focuses attention on the particularly devastating impact HIV is having in Washington, DC, and in racial and ethnic minority communities across the U.S.

http://www.aids2012.org/

19–20 July 2012 7th International Workshop on HIV Transmission

Renaissance Washington, DC Downtown Hotel, 999 Ninth Street NW, Washington, District Of Columbia, 20001 USA

Over the years, advances in HIV treatment have led to an enhanced understanding of the virus and improved care of HIV infected patients. However our insights into the spread of the HIV virus remain limited. A more extensive exchange of knowledge on the various aspects of HIV transmission provides important perspectives for a better approach to the epidemic. For this purpose, an integrated forum was set up in 2006 to reveal perspectives of experts from different fields enabling discussion on all relevant mechanisms of HIV transmission. The annual Transmission Workshops have since continued to prove themselves valuable to those specialized (or specializing) in HIV transmission.

http://www.virology-education.com/index.cfm/t/7th_International_Workshop_on_HIV_Transmission___Principles_of_Intervention/vid/D7E4C48B-EED3-9192-8A0B47BA790E00E4

18–19 June 2012 Structural Biology Related to HIV/AIDS - 2012

Natcher Conference Center, NIH Campus, Bethesda, Maryland 20892, USA

NIGMS, NIAID, and the NIH Office of AIDS Research invite you to the Annual AIDS-Related Structural Biology meeting to be held at the NIH on June 18-19.
Since 1987, NIGMS has supported research and center grants to determine the structure of AIDS-related proteins.  The focus of NIGMS-supported HIV studies has evolved from determining the structures of AIDS-related proteins and developing structure-based drug design techniques to identifying mechanisms of drug resistance and complexes of host and viral proteins essential to the HIV life cycle.  This year will mark the completion of first funding phase for the NIGMS Centers for HIV/AIDS-Related Structural Biology.  The meeting will provide these centers with the opportunity to summarize their accomplishments during their first 5 years, as well as an opportunity for ongoing Program Projects and R01 Investigators to share their progress and ideas with the community.

http://meetings.nigms.nih.gov/index.cfm?event=home&ID=13466

23–25 May 2012 ISHEID 2012

Marseille, France

Despite major advances in the past 25 years, HIV infection remains a global threat with major scientific, societal and human challenges ahead. With an economic crisis able to undermine public investments, access to HIV prevention, HIV treatment and care are in jeopardy.
The ISHEID seeks to promote scientific excellence and to strengthen the global commitment against HIV/AIDS. It presents new scientific knowledge and offers many opportunities for structured dialogue on the major issues facing the global response against HIV/AIDS.

The 2012 programme will focus on current ‘hot topics’ in HIV research: understanding the mechanisms of HIV persistence and maintenance in reservoirs, trying to find a cure…, but also on socioeconomic and policy aspects. Different sessions will tackle ‘Human Rights & HIV/AIDS’, ‘Prevention of HIV Transmission’, ‘Access to Care’... Ultimately, the meeting will also address recent findings in the fields of viral hepatitis and emerging infectious diseases which need the same kind of global approach.

A variety of session types – from abstract-driven presentations to symposia, workshops and plenary lectures – will meet the needs of various participants. This human scale conference allows to meet international Key Opinion Leaders in a friendly atmosphere, to exchange ideas and to share experience. Consequently, the 2012 ISHEID will offer an exceptional opportunity for professional development and networking.

See you in Marseille in 2012!

Alain Lafeuillade
Symposium Chairman

http://www.isheid.com/en/home/welcome.html

25–28 April 2012 19th International HIV Dinamics & Evolution

Marriott RenAsheville, North Carolinia, USA

This meeting series was initiated to promote discussion between specialists in quantitative and computational approaches in two areas in the field of HIV where these are particularly important.

  1. Modeling of viral and cellular dynamics
  2. Viral evolution and population genetics

Conference sessions will be organized to accommodate the best submitted talks. We welcome submissions on all topics on statistical, mathematical and computational approaches to analyzing HIV's dynamics and evolution.

Topics to be covered will include:

  • HIV Dynamics Within the Host (transmission, disease progression, dual infection, recombination)
  • HIV Dynamics Within the Population (epidemiology, phylodynamics, global diversity, paleovirology)
  • New Computational Methods and Evolutionary Theory
  • Evolution of the Host Response (host response to infection at the individual and at the population level
  • Viral Dynamics and Evolution that Impact Vaccine Development and Drug Resistance

http://cme.ucsd.edu/hivdynamics/index.html

26–31 March 2012 Keystone Symposia’s 2012 Meeting: Frontiers in HIV Pathogenesis, Therapy and Eradication

Whistler, BC, Canada

AIDS is incurable because cells latently infected with HIV resist antiviral therapy. Topical to the discussion of HIV eradication is the biology behind latent infection as well as models for the study of latency and pharmacological approaches to stimulate proviral gene expression. The Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication will create an environment for free exchange of ideas and cutting-edge results from a range of scientists in academia and industry in the fields of HIV pathogenesis, pharmacology and eradication.

http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1166

26–31 March 2012 Frontiers in HIV Pathogenesis, Therapy and Eradication

Whistler Conference Centre, Whistler, British Columbia, Canada

Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation

Meeting Summary

AIDS is incurable because cells latently infected with HIV resist antiviral therapy. Topical to the discussion of HIV eradication is the biology behind latent infection as well as models for the study of latency and pharmacological approaches to stimulate proviral gene expression. The Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication will create an environment for free exchange of ideas and cutting edge results from a range of scientists in academia and industry in the fields of HIV pathogenesis, pharmacology, and eradication. Joint plenary sessions with the concurrent meeting on Cell Biology of Virus Entry, Replication and Pathogenesis will highlight common topics of interest including mechanisms of virus entry and inhibition, and will significantly enhance opportunities for interdisciplinary interactions. Leaders from HIV replication and drug resistance fields will critically examine the state of antiviral therapy, novel inhibitors, and important virus-host interactions. Speakers selected from submitted abstracts will fill-out workshops on pharmacological approaches and the cell biology of HIV infection.

http://www.keystonesymposia.org/meetings/viewMeetings.cfm?MeetingID=1166

14–15 February 2012 1st Biotechnology World Congress

Dubai, UAE

This unique international conference provides a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. Four Nobel Laureates and many world renowned experts will participate at the conference.

The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include latest researches, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.

Throughout the course of the two day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate biotechnology communities.

The conference is organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, and it focuses on the interdisciplinary fields of biotechnology.

http://www.biotechworldcongress.com/

6–9 December 2011 Fifth International Workshop on HIV Persistence during Therapy

Radisson St. Martin Hotel, St. Martin, West Indies

I am delighted to announce the Fifth International Workshop on HIV Persistence during Therapy, scheduled for December 6-9, 2011 at the Radisson St. Martin Hotel, St Martin.
Since the first edition of this workshop in 2003, the issue of “HIV Persistence & Reservoirs” has become more relevant, not only for the biologist but also for the clinician facing the problem of the long-term control of this persistent retroviral infection.

As effectively treated patients experience neurocognitive dysfunction, premature aging, and persistent inflammation, more attention is paid to these reservoirs. Furthermore, not all hope on finding a cure is scientifically lost. We have already made great strides in our search for a cure by a better understanding of the mechanisms involved in HIV persistence and are ready to test new strategies designed to achieve either a functional or a sterilizing cure.
This workshop is unanimously recognized as “The Reference Workshop on HIV Reservoirs & Eradication Strategies.” The program format will continue to follow the past successes and include presentation of new, unpublished data and a panel of experts to sum up the current advances in the field. The number of participants is limited and registration only possible for those having submitted a relevant abstract. As in the past, abstract selection will be extremely rigorous and conducted by the Scientific Committee.

I hope to see you in December in Saint Martin!
Alain Lafeuillade, MD, Chair

http://www.informedhorizons.com/persistence2011/index.html

4–8 December 2011 HEPDART 2011 - Frontiers in Drug Development for Viral Hepatitis

Grand Hyatt Kauai Koloa, Kauai, Hawaii

For further informations:
Please have a look at the homepage.

http://www.informedhorizons.com/events.html#

20–23 October 2011 49th Annual Meeting of the Infectious Diseases Society of America

Boston, MA, USA

Join us for the 49th Annual Meeting of the Infectious Diseases Society of America in Boston, Massachusetts on October 20-23, 2011.
The meeting will bring together physicians, scientists, and other health care professionals involved in research, patient care, public health, disease prevention, and education in the field of infectious diseases.

http://www.idsociety.org/Content.aspx?id=17142

18–21 September 2011 8th International Retroviral NC Symposium (8th IRNCS)

Caixa Forum & Catalonia Plaza Hotel, Barcelona, Spain

After 14 years of intensive research since the first NC symposium, especially that dedicated to HIV, the purpose of this 8th International Retroviral NC Symposium is to exchange the latest results and ideas related to retroviral Nucleocapsid (NC) Proteins and functionally homologous proteins in other viruses. The Symposium will be held in Barcelona Spain at the contemporary art museum CaixaForum, giving the organizers the opportunity to provide you with a very stimulating atmosphere.
The topics to be presented will cover up-to-date concepts of modern biology, supported by the latest applications of physics and biotechnologies, in particular new microscopic methods. There will also be a special session dedicated to HIV-1 NC-related transversal research.
Invited speakers have been selected for their outstanding contributions in the NC field. Due to the auditorium size, the symposium will be limited to 120 people so we suggest you to avoid late registration.

On behalf of the organizing committee, welcome to the 8th IRNCS,
Gilles Mirambeau

http://www.ncsymposium2011.org/

17–20 September 2011 51st ICAAC

Chicago, IL, USA

Join 10,000 of your colleagues from around the world at the world's premier meeting on infectious diseases and antimicrobial agents.
This fall, world renowned scientists will converge in Chicago to exchange information and foster global solutions to scientific challenges such as HIV/AIDS, anthrax, smallpox, SARS, bioterrorism preparedness, recognition, detections, and medical treatments. Through abstracts, symposia, and other educational opportunities ICAAC will provide timely information that will improve healthcare and the management of infectious diseases.

http://www.asm.org/index.php/meetings/icaac.html

6–16 September 2011 IUMS Congresses 2011

Sapporo, Hokkaido, Japan

Dear Colleagues,

We would like to welcome you to the IUMS Congresses 2011, which will be held in the beautiful city of Sapporo (in Hokkaido, the northernmost island of Japan) from the 6 – 16 September 2011, and hosted by the Federation of Microbiological Societies of Japan.

There will be three congresses: the XIII International Congress of Bacteriology and Applied Microbiology (6-10 September, 2011), the XIII International Congress of Mycology (6-10 September, 2011 and the XV Congress of Virology (11-16 September, 2011). There will also be two outreach activities to the general public which will be held in order to publicise the importance of microbial science and technologies and their relationship to our everyday life. We expect them to provide a deeper understanding of our activities and increase the public's familiarity with them.
IUMS Congresses are international conferences that bring together a wide range of experience and perspectives. Some microbes are a threat to humankind, but on the other hand many of them are essential for human life on Earth. Over many years we have accumulated a vast knowledge of microbes. Current research is showing us that microbes have 'unlimited capabilities' thus our congresses logo was set as "Unlimited World of Microbes". IUMS 2011 will be a magnificent opportunity not only to share ideas and experiences but also to establish and improve friendships among colleagues from all over the world. Finally, we welcome you all again to the exciting congresses and to the beautiful city of Sapporo, the capital of Hokkaido, and to the beautiful Fall season of the North island.

http://www.congre.co.jp/iums2011sapporo/

19–21 August 2011 Workshop on Novel Viruses Associated with Human Cancer

Graves Mountain Lodge, Syria, VA, USA

A workshop on Novel Viruses Associated with Human Cancer will be held on August 19-21, 2010, at the Graves Mountain Lodge, Syria, VA.  Viruses have an etiologic role in 20-25% of human cancers, and it is possible that additional viruses may also be involved. The workshop will bring investigators working on established human cancer viruses with those studying novel human viruses that may be associated with human cancers.  The goal is to promote exchange among workers on these different viruses, in which experiences from established cancer viruses provide perspectives for the new candidate cancer viruses.
The meeting will begin on Thursday evening and conclude on Saturday evening after dinner. Registration includes lodging for the nights of August 19, 20 and 21, allowing for departure on Sunday, August 22nd.  Registrants are invited to submit abstracts for posters and selected oral presentations.

http://www.cri.bio.uci.edu/Meetings/Viral/

24–26 July 2011 Recent Advances in Pathogenic Human Viruses

Guangzhou, China

The meeting will begin with an opening reception in one of the convention hotels on the evening of July 24, 2011.  The scientific meeting will be two full days, July 25 - 26, 2011 and conclude with a closing banquet on the evening of July 26th.

http://www.asbmb.org/ASBMBMeetings/SpecialSymposia/Symposia.aspx?mid=14

17–20 July 2011 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention

Rome, Italy

The world’s largest open scientific conference on HIV/AIDS – the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) will be held in Rome Italy in July 2011. The event will be organized by the IAS, in partnership with Istituto Superiore di Sanità (Italian National Institute of Health), which is the leading technical and scientific body of the Italian National Health Service.

The scientific programme of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention aims to provide new insights into HIV disease development, biomedical prevention, clinical care that can lead to novel research directions and help translate theoretical advances into clinical and prevention practice while building evidence for successful programme operations and implementation. The Scientific Programme Committee is dedicated to ensuring that the content will be relevant to today’s questions, including addressing the challenges of expanding treatment and prevention in resource-limited settings. An additional priority is ensuring that the presentations focus on the latest HIV science and its practical applications for public and individual health in the context of where the epidemic will be in 2011.
In addition to abstract-driven sessions, the conference will offer daily plenary sessions featuring distinguished researchers, scientific leaders and clinical experts. Other non–abstract-driven sessions include Symposia, focusing on a single, clearly defined topic or issue; Bridging Sessions, which will provide an opportunity for a multi-disciplinary, cross-track discussion of a single issue from a variety of viewpoints; Controversies, which will offer frank and open exchange of views on the major controversies in the science of HIV/AIDS; and Special Sessions with some of the world’s key research leaders, high-level international AIDS Ambassadors and policy specialists. New to IAS 2011 will be professional development workshops. The Scientific Programme Committee will select a dozen of the world's top topics and teachers to offer a variety of targeted workshops aimed at strengthening the skills and expanding the knowledge of HIV professionals.

http://www.iasociety.org/Default.aspx?pageId=77

16–20 July 2011 30th Annual American Society for Virology Meeting

University of Minnesota, Twin Cities, Minneapolis Campus, MN, USA

The American Society for Virology invites you to participate in the 30th Annual Meeting, being hosted and held at the University of Minnesota, in Minneapolis, Minnesota.
The American Society for Virology (ASV) was founded in 1981 to provide a forum for investigators of human, animal, insect, plant, fungal, and bacterial viruses, whether the research involves the use of clinical, ecological, biological, or biochemical approaches. The Society sponsors an annual meeting, designed to promote discussion and collaboration among scientists active in all aspects of virology.

http://www.cce.umn.edu/American-Society-for-Virology-Meeting/

14–15 July 2011 6th International Workshop on HIV Transmission - Principles of Intervention

Rome, Italy

Dear Colleagues,

Over the years, advances in HIV treatment have led to an enhanced understanding of the virus and improved care of HIV infected patients. However our insights into the spread of the HIV virus remain limited. A more extensive exchange of knowledge on the various aspects of HIV transmission provides important perspectives for a better approach to the epidemic. For this purpose, an integrated forum was set up in 2006 to reveal perspectives of experts from different fields enabling discussion on all relevant mechanisms of HIV transmission. The annual Transmission Workshops have since continued to prove themselves valuable to those specialized (or specializing) in HIV transmission.

The main objectives of this meeting are to provide a forum for basic scientists, clinicians, virologists, epidemiologists and public health officials to present and to discuss the various aspects of the transmission of HIV. The ultimate goal of the meeting is the integration of efforts from all relevant disciplines in order to constrain the spread of (drug-resistant) HIV.

The workshop addresses the following important topics:
•     Biology of HIV transmission
•     Virology of HIV transmission events
•     Epidemiology & modelling of HIV transmission
•     Mother-to-child transmission
•     Transmission of drug-resistance
•     Biomedical approaches for HIV prevention of sexual transmission
•     Social sciences & behavioural risk factors

We are pleased to announce the organization of a 6th International Workshop on HIV Transmission in Rome, Italy on 14, 15 July 2011.
We are looking forward to a full program of invited lectures, oral and poster presentations and roundtables.
For additional information on invited speakers, topics and online registration, we invite you to stay tuned to this website. Updates will be posted regularly.
We look forward to welcoming you all in Rome in 2011!

The Organizing Committee

http://www.virology-education.com/index.cfm/t/6th_International_Workshop_on_HIV_Transmission___Principles_of_Intervention/vid/0F10B30E-DF73-0B15-5CA03C16D39CF58C

23–24 June 2011 6th International Workshop on Hepatitis C, Resistance and New Compounds

Boston (Hyatt Regency Cambridge), MA, USA

Dear Colleagues,

We are delighted to announce the 6th edition of the International Workshop on Hepatitis C, Resistance and New Compounds.
Over the years, this workshop has become the leading event on Hepatitis C resistance. Scientists from both academia and industry have attended the conference in increasing numbers, attracted by the high level of science and the closed nature of the workshop that encourages participants to share their knowledge and latest findings.
The International Workshop on Hepatitis C, Resistance & New Compounds provides a platform for scientific presentations and discussions for those interested in the area of antiviral drug development and antiviral drug resistance.
We bring together scientists representing different disciplines (chemistry, virology, hepatology, immunology, infectious disease) to facilitate cross-discipline interaction and debate. 
Areas of particular interest are: identification of new targets and compounds, novel screening approaches, in vitro efficacy and resistance evaluations, the basic and evolution of resistance and cross resistance, in vivo efficacy measures, tools for monitoring resistance in the clinic as well as clinical correlates of resistance development.
The core of the meeting consists of abstract-driven sessions introduced through invited lectures by leaders in the field. In addition, round table discussions and poster presentations ensure an interactive atmosphere.
We look with great optimism to the 2011 workshop that will be held in Boston (Hyatt Regency Cambridge), 23 and 24 June 2011.
Due to the success of last year's back-to-back format with the International Workshop on Clinical Pharmacology of Hepatitis, the two workshops will again be held in close proximity to each other, with a joint session on tangential topics linking them together.

We look forward to another inspiring meeting!

The Organizing Committee

http://www.virology-education.com/index.cfm/t/6th_International_Workshop_on_Hepatitis_C___Resistance_and_New_Compounds/vid/0EEF6D2C-CF04-C883-1A229790D22E076D

7 June–11 July 2011 International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies

Sheraton Hacienda del Mar, Los Cabos, Baja California Sur, Mexico

The International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies has gained a reputation over the past 19 years as the premier meeting on antiviral resistance.  Leading laboratory and clinical scientists present their latest research at this Workshop, which often results in innovative approaches to antiviral therapy.  The Workshop is renowned for the quality of the data presented and the depth of the scientific interaction and debate.
This year the workshop is being held at the Sheraton Hacienda del Mar in Los Cabos, Baja California Sur, Mexico on June 7-11, 2011.
The Workshop continues to attract the most prominent scientists and clinicians, thereby maintaining the Workshop's excellent reputation for cutting-edge science and service. Additionally, through support of our Funding Partners, scholarships are available for young scientists and community representatives.

HBV/HCV Resistance
In view of the rapidly expanding area of HBV/HCV drug development and the many parallels with antiretroviral therapy, the Scientific Committee is building on last year’s success with the addition of HBV/HCV resistance content.
HIV Drug Resistance in Resource Poor Countries
One of the topics that will be highlighted at this year’s Resistance Workshop is the emergence of HIV drug resistance as a consequence of the global expansion antiretroviral therapy. In past years, the number of people receiving antiretroviral therapy in low and middle-income countries has increased. This enormous progress is potentially threatened by the selection and transmission of HIV drug resistance. It is important that all scientists investigating HIV drug resistance internationally share data and ideas, as well as develop potential synergistic collaborations.
Investigators working on HIV-1 drug resistance in developing countries are strongly encouraged to submit abstracts describing their latest findings to the Workshop.
HIV-1 Persistence, Reservoirs and Elimination Strategies
Current antiretroviral therapy suppresses HIV-1 infection but cannot eradicate it because there are long-lived cellular reservoirs that are latently infected or that chronically produce HIV-1. These reservoirs are likely to be the source of residual low-level viremia on antiretroviral therapy, although ongoing, complete cycles of HIV-1 replication have not been excluded. The persistence of HIV-1 requires new insights into the molecular basis of latency, the cellular and anatomic reservoirs of HIV-1, the immunopathogenic consequence of viral persistence, and novel approaches to reduce or eliminate viral expression and cellular reservoirs.
Investigators working on HIV-1 persistence, reservoirs and elimination strategies are strongly encouraged to submit abstracts describing their latest findings to the Workshop.

http://www.informedhorizons.com/resistance2011/

1–3 June 2011 7th International Workshop on HIV & Hepatitis Co-infection

Milan Marriott Hotel, Milan, Italy

Dear Colleagues,

We are proud to announce the 7th International Workshop on HIV & Hepatitis Co-infection, to be held on 1-3 June 2011 at the Milan Marriott Hotel in Milan, Italy.
This annual workshop has become recognized as the leading medical gathering for those involved in the clinical care of individuals living with HIV and Hepatitis. The select nature of the venue and program provides an excellent platform to exchange the latest scientific and medical information and to discuss it with the experts active in the different disciplines (including Virology, Hepatology, Immunology, Infectious Disease and Primary Care).
This year's edition will continue to focus on developments in basic science, emerging therapies and clinical management. It will emphasize translational research and best practices in the clinical management of Hepatitis and HIV co-infection.
The informal format of the workshop will include plenary expert presentations, controversy discussion sessions on areas currently lacking consensus, and abstract-driven presentations. Experts in the field will be invited to give state-of-the-art lectures and controversial cases which will be discussed by expert panels. The target audience consists of scientists and clinicians caring for co-infected patients.
We welcome you to attend the 7th International HIV and Hepatitis Co-infection Workshop in Milan and encourage you to submit abstracts on your recent research.
If you are interested in supporting this workshop, please contact Alice Posthumus-Plantinga at Virology Education regarding the sponsorship possibilities.

The Organizing Committee

http://www.virology-education.com/index.cfm/t/7th_International_Workshop_on_HIV___Hepatitis_Co_Infection/vid/0EA288D8-E1B4-90C2-67C8BBFFB9CBB609

23–28 May 2011 6th Annual Meeting on Retroviruses

Cold Spring Harbor, NY, USA

We are pleased to host the 36th annual meeting on Retroviruses which will begin at 7:30 p.m. on Monday May 23 and end after lunch on Saturday May 28, 2011.
We are looking forward to a broad-based meeting, and abstracts are welcomed on all aspects of retrovirology.

http://meetings.cshl.edu/meetings/retro11.shtml

8 May 2011 2010 UCI Campuswide Symposium on Basic Cancer Research

105 Sprague Hall, Irvine, CA, USA

For further informations:
Please have a look at the homepage.

http://www.cri.bio.uci.edu/

8–11 May 2011 24th International Conference on Antiviral Research (24th ICAR)

Sofia, Bulgaria

Dear Friends and Colleagues,

ICAR is returning to Europe! The 24th International Conference on Antiviral Research will be held at Kempinski Hotel Zografski Sofia, Bulgaria. The Conference will begin on Sunday, May 8, 2011 and end on Wednesday, May 11, 2011. with an Interactive Workshop titled Drug Discovery and Development 101, the opening ICAR keynote presentation and welcoming reception and end with the closing banquet on Wednesday, May 11, 2011.

The ICAR provides an interdisciplinary forum at which investigators involved in basic, applied, and clinical research worldwide can meet to review recent developments in all areas of antiviral research and development. Specific topics to be covered in the program include medicinal chemistry, new target identification, biochemistry and mechanism of action, assay development, in vitro evaluation, animal models, pharmacokinetics, toxicology, and clinical trials. Within these areas of interest, there will be invited overview speakers, oral presentations, and poster presentations.
The meeting provides a truly interdisciplinary view of cutting-edge antiviral drug research and development that should be of interest to chemists, biologists, and clinicians.

We look forward to seeing you there.

ISAR Conference and Program Committees

http://isar.phrm.cf.ac.uk/node/78

13–15 April 2011 12th International Workshop on Clinical Pharmacology of HIV Therapy

Miami FL, USA

Dear Colleagues,

We are pleased to announce the 12th International Workshop on Clinical Pharmacology of HIV Therapy, to be held in Miami FL, USA, on 13-15 April, 2011.
Understanding the clinical pharmacology of antiretroviral therapy is pivotal to designing optimal treatment and prevention strategies for HIV infection.  We know that drug exposure is significantly influenced by drug interactions, non-adherence, and patients’ physiologic and genetic characteristics.  These factors are central to determining therapeutic efficacy, failure or toxicity.  Despite great progress, many pharmacologic challenges still exist.
The 12th edition of the International Workshop on Clinical Pharmacology will present the current state-of-the-art on the use of antiretroviral agents in preventing and curing HIV infection, in addition to predicting important toxicities, antiretroviral challenges in an aging population, and antiretroviral use in resource-poor countries.  The workshop will also provide a comprehensive update of current topics fundamental to the optimal use of antiretroviral therapy, such as newly detected drug-drug interactions, pharmacokinetics of investigational agents, drug dosing in special populations, and post-marketing surveillance projects.
We hope you will be able to join us this year and we look forward to seeing you in Miami.

The Organizing Committee

http://www.virology-education.com/index.cfm/t/12th_International_Workshop_on_Clinical_Pharmacology_of_HIV_Therapy/vid/FA13B631-92B9-A094-492853C05FD3A11A

28–30 March 2011 25th Annual Meeting of the Groups Studying the Structures of AIDS-Related Systems and Their Application to Targeted Drug Design

Ruth L. Kirschstein Auditorium Bethesda, MD, USA

NIGMS invites you to the 25th Annual AIDS-Related Structural Biology meeting to be held at the NIH on March 28-30, 2011.
Since 1987, NIGMS has supported research and center grants to determine the structure of AIDS-related proteins. The focus of NIGMS-supported HIV studies has evolved from determining the structures of AIDS-related proteins and developing structure-based drug design techniques to identifying mechanisms of drug resistance and host proteins related to the HIV life cycle. This year marks the 25th anniversary of the creation of this initiative by former NIH Director Dr. Jim Wyngaarden and Dr. Marvin Cassman, former director of the Biophysics and Physiological Sciences program at NIGMS.  The meeting will provide the community with an opportunity to reflect on past accomplishments and describe current advances and develop ideas for future NIGMS AIDS-related funding opportunities.
The meeting will take place on the NIH campus in Bethesda. Plenary sessions will cover the HIV life cycle, host-pathogen interactions, imaging, latency, viral host recognition and structure-based drug design and resistance. The first two days will also include afternoon poster sessions and breakout discussion groups on the future of NIGMS AIDS research initiatives. Principal investigators, postdoctoral fellows and students are welcome to attend. The meeting is free and open to the public, but advance registration is required. If you’d like to submit a poster presentation, click the "

http://meetings.nigms.nih.gov/?&id=10905

23–25 March 2011 9th European Workshop on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance

Coral Beach Hotel & Resort, in Paphos, Cyprus

This meeting is a continuation of the very successful European HIV Drug Resistance Workshops, that have proven very valuable to European researchers and clinicians working in the field of HIV. This annual European workshop has become the place-to-be to keep abreast of the latest scientific developments in the field of antiviral drug resistance and to translate the latest science to daily clinical practice.
The meeting spans a two and a half-day program consisting of invited lectures, abstract driven scientific presentations, clinical case presentations and poster sessions. The workshop will address important topics, such as mechanisms and clinical implications of drug resistance, development of novel drugs, epidemiology of drug resistance, resistance to new drugs, resistance technology, managing HIV-HCV/HBV co-infection, etc.

http://www.virology-education.com/index.cfm/t/9th_European_Workshop_on_HIV___Hepatitis__Treatment_Strategies___Antiviral_Drug_Resistance/vid/FA12B82A-DB5C-1EB3-73ACAC2CD2B8BA0E

20–25 March 2011 HIV Evolution, Genomics and Pathogenesis (X7)

Whistler Conference Centre, Whistler, British Columbia, Canada

Elucidating the molecular mechanisms of HIV pathogenesis relies on understanding the complex interplay between the virus and its host. Increasingly, the field is relying on the power of comparative studies of similar viruses in other species, and on whole genome analyses to elucidate which pathways are critical. The use of evolutionary analyses of both host and virus is also providing novel insights into viral transmission and innate immune responses. This Keystone Symposia meeting will use diverse disciplines to promote further insights into the dynamic interplay between the virus and the host in areas of pathogenesis, mucosal biology, the roles of viral and host genes, and viral latency. Understanding these issues is critical for the design and development of an effective vaccine and the next generation of antiviral agents.

http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1109

20–25 March 2011 Protection from HIV: Targeted Intervention Strategies (X8)

Whistler Conference Centre, Whistler, British Columbia, Canada


Biological efforts to prevent HIV infection center on four independent approaches: inducing adaptive immune responses through vaccination, augmenting innate responses, using peri-exposure prophylactic drug therapy, and developing microbicides and/or recombinant antiviral microbial products. While all four of these approaches have promise, they still require significant optimization and further clinical trials. Indeed, successful prevention of HIV infection will likely require a combination of these approaches. Such development efforts require a better understanding of viral and immunological events at the site of transmission. This Keystone Symposia meeting will have a focus on mucosal immunology as well as the interplay between the virus and innate and adaptive immune responses, particularly during the acute phase of the infection. Leading experts in the fields will discuss recent scientific advances in these varied approaches to preventing infection and present data from recent clinical trials testing their efficacy.

http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1110

10–13 March 2011 2011 Palm Springs Symposium on HIV/AIDS

Palm Springs, CA, USA

The 2010 Palm Springs Symposium is organized by the UCLA AIDS Institute and the UCI Cancer Research Institute. Previous symposia have addressed gene therapeutic approaches and novel therapeutic strategies for treatment of HIV-1 infection. The objective of the fifteenth annual symposium is to bring together some of the most highly regarded leaders in the field of AIDS and vaccines to share their expertise in an intimate setting. It is designed to generate productive interactions between scientists working on different aspects of the topics. The symposium will be held at the Hyatt Regency Suites in Palm Springs, California. The size of the meeting will be limited to ensure that the interactive atmosphere of past meetings is maintained.
Located within Southern California's golden triangle, Palm Springs has over 300 sunny days per year, 93 golf courses, 10,000 swimming pools and 600 tennis courts. Because of this, Palm Springs provides a relaxed atmosphere in which attendees and faculty can engage in one-on-one conversations as well as enjoy the recreational opportunities that this golden city offers.

http://www.cri.bio.uci.edu/Meetings/PS2003/index.html

27 February–2 March 2011 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)

Boston, MA, USA

Over 4,000 leading researchers and clinicians from around the world will convene in Boston, Massachusetts from February 27 through March 2, 2011 for the 18th Conference on Retroviruses and Opportunistic Infections (CROI). CROI is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic.
The subjects that will be highlighted are:

- virology (including HIV and all other retroviruses)
- molecular epidemiology (including distribution and diversity of retroviruses)
- HIV immunology
- pathogenesis of HIV-mediated Immunodeficiency
- neuropathogenesis and neurologic complications
- HIV transmission and primary/acute infection
- preventive HIV vaccines (including preclinical candidates and clinical trials)
- therapeutic HIV vaccines and immune-based therapies (including cytokines)
- human genomics
- antiretroviral therapy (preclinical, randomized clinical trials, observational studies, and complications)
- HIV drug resistance (including molecular mechanisms, pathogenesis, clinical implications, epidemiology, and resistance diagnostics)
- clinical pharmacology
- complications of HIV infection
- opportunistic infections (including basic science, immunology, pathogenesis, epidemiology, and other clinical studies)
- hepatitis virus co-infections
- AIDS-related malignancies
- pediatrics/adolescents
- maternal/fetal
- HIV in women/women's health
- novel diagnostic technologies and new monitoring tools
- epidemiology of HIV infection
- sexually transmitted infections (non-HIV including basic science, immunology, pathogenesis, epidemiology, and other clinical studies)
- prevention studies (including microbicides, pre-exposure prophylaxis, circumcision, and behavioral interventions)
- research on delivery of care in developing countries (including operational research and implementation)

CROI 2011 will feature the sixteenth Bernard Fields Memorial Lecture, the fifth N'Galy Mann Lecture, plenary lectures that will be highly scientific in nature, roundtable symposia that will present and debate controversial scientific issues, several hundred original oral and poster abstract presentations of new data, and late breakers that will consist of important preliminary research findings.

http://www.retroconference.org/2011/

9–10 February 2011 The Thirteenth Annual Chao Lecturship in Cancer Research

Tamkin Lecture Hall (F-110), UC Irvine Campus, Irvine, CA, USA

Daniel D. Von Hoff, M.D., is currently Professor of Medicine, Pathology, Molecular and Cellular Biology, Director of the Arizona Health Sciences Center's Cancer Therapeutics Program, Executive Vice President, Translational Genomics Research Institute (TGen), Director, TGen's Translational Drug Development Division and Head, Pancreatic Cancer Research Program. He is also Chief Scientific Officer for US Oncology.
Dr. Von Hoff's major interest is in the development of new anticancer agents, both in the clinic and in the laboratory. He and his colleagues were involved in the beginning of the development of many of the agents we now use routinely, including: mitoxantrone, fludarabine, paclitaxel, docetaxel, gemcitabine, CPT-11, and others. At present, he and his colleagues are concentrating on the development of molecularly targeted therapies.
Dr. Von Hoff's laboratory interests and contributions have been in the area of in vitro drug sensitivity testing to individualize treatment for the patient. He and his laboratory are now concentrating on discovery of new targets in pancreatic cancer. Dr. Von Hoff has published more than 515 papers, 127 book chapters, and more than 850 abstracts. Dr. Von Hoff was appointed to President Bush's National Cancer Advisory Board in June 2004 - March 2010. Dr. Von Hoff is the past President of the American Association for Cancer Research, a Fellow of the American College of Physicians, and a member and past board member of the American Society of Clinical Oncology. He is a founder of ILEXTM Oncology, Inc. (recently acquired by Genzyme). He is founder and the Editor Emeritus of Investigational New Drugs - The Journal of New Anticancer Agents; and, Editor-in-Chief of Molecular Cancer Therapeutics.
He is also proud to have been a mentor and teacher for multiple medical students, medical oncology fellows, graduate students, and post-doctoral fellows.

http://www.cri.bio.uci.edu/Chao_Lecture_Von_Hoff.html

9 February 2011 Atlanta ACG Capital Connection

Cobb Galleria Centre, Atlanta, GA, USA

The Atlanta ACG Capital Connection is a forum hosted by ACG Atlanta and has become the premier networking and educational event in the Southeast for participants in all facets of corporate growth and deal making. The event presents the opportunity for intermediaries, CFO's, accountants, lawyers and other deal makers to meet and greet with top private equity principals. All of the prior seven Atlanta ACG Capital Connection conferences have been sold out events. Attendance has grown from 411 in 2003, to over 1,000 by 2010. We expect another sell out in 2011, including at least 85 Private Equity Group and 50 Reverse Capital Connection exhibitors. The follow-up response to the event was overwhelmingly positive, with 99% of survey respondents indicating above average satisfaction with the event.

http://www.informedhorizons.com/acg2011/

6–9 February 2011 ASM Conference on Viral Genome Replication

Banff, Canada

The conference will focus on mechanisms employed by different classes of DNA and RNA viruses for genome replication. It is intended to provide a unique podium to discuss, to compare, and to contrast the involvement of viral and cellular factors in replication processes. Biological, methodological, and clinical perspectives will be covered. The transfer of knowledge from basic research to modern drug discovery and development efforts is yet another goal of this meeting. Scientists in academia and industry are welcome to attend.

Topics will include:
- Genome Replication Strategies, Elements, Factors, & Enzymes: Structure-function and mechanism
- Antivirals: Targets, mechanisms and resistance

Additional talks and topics will be selected from submitted abstracts.

http://www.asm.org/index.php/meetings/asm-conference-on-viral-genome-replication.html

15–16 January 2011 2011 Gordon-Keenan Research Seminar (GKRS) on Physical Virology

Ventura Beach Marriott, Ventura, CA, USA


The Gordon-Kenan Research Seminar on Physical Virology is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas relevant to the area of virus-inspired systems.

Virus capsids, in particular, have properties that have elicited an increased interest for various applications of potential technological importance, e.g., responsiveness to environmental changes, the ability to spontaneously and efficiently self-assemble in vitro or in vivo with sub-nanometer accuracy, and the possibility of structural engineering using established molecular biology methods.

The focus of this meeting is on:

1. providing a non-intimidating forum for the discussion of physical, biological, and materials perspectives that are rapidly shaping the field of viruses as physical functional systems, and

2. providing career mentorship by addressing the challenges and opportunities related to interdisciplinary research, including:
a) how to create one's niche in a diverse field
b) what types of jobs are available to applicants with an interdisciplinary background
c) how the continuous evolution of this field might impact future career prospects

http://www.grc.org/programs.aspx?year=2011&program=grs_phsyvr

2–4 December 2010 Influenza: Translating Basic Insights

Washington Marriott Hotel, Washington D.C., USA

Given the recent influenza pandemic, the last 12 months have seen a flurry of activity in the area of flu research. New insights are being gained about the biology of the virus, the host immune response, and the ability of the virus to overcome species barriers and host-immune defenses. The broader goal of influenza research is to extrapolate these basic insights for better control of disease, and to develop better vaccines and anti-viral therapeutics. This meeting aims to foster interactions among a broad group of scientists studying the influenza virus from multiple perspectives including: the virus itself, the host response to viral infection, the clinical manifestations of pandemic and seasonal influenza, as well as those scientists actively working to develop better vaccines and therapeutics in an industrial setting.

This meeting aims to bring basic scientists, clinicians, epidemiologists and applied biotechnology and pharmaceutical researchers together to build a translational bridge between basic influenza research and the development of drugs, vaccines and diagnostics for the flu.

http://www.cell-symposia-influenza.com/

7–9 November 2010 Antivirals Congress

NH Grand Hotel Krasnapolsky, Amsterdam, The Netherlands

Antiviral Research, the most comprehensive and pre-eminent journal for those interested in the effective control of virus infections in animals and humans, as well as in plants and lower organisms, will celebrate its 30th anniversary in 2010. To celebrate this anniversary, the Editors and the Publisher of the journal are delighted to announce an \'Antivirals Congress\', to be held in Amsterdam in November 2010. The key objectives of the congress are:

  • To provide a progressive state-of-the-art report for scientists, governmental authorities and healthcare workers
  • To accelerate progress in the development of antivirals, including small molecules and biologics

The congress will serve as an interface between academics, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.

Attendance at this conference will enable you to:

  • access unique, high quality content in the growing field of antivirals
  • learn from experts and opinion leaders in various therapeutic fields
  • present their latest findings as an oral or poster presentation
  • network with delegates from over 30 countries

To supplement a number of invited keynote presentations, contributions are invited for oral and poster presentations on the following topics:

  • Antivirals - preclinical
  • Antivirals - clinical development
  • Host-virus interactions
  • Immunology / Animal models
  • Production / Manufacturing / Safety
  • Regulatory / Societal / Legislation aspects

http://www.antivirals.elsevier.com/

7–10 November 2010 11th Annual Symposium on Antiviral Drug Resistance

Hershey, USA


Dear Colleagues:

We are pleased to announce that the 11th Annual Symposium on Antiviral Drug Resistance: Targets and Mechanisms will be held November 7-10, 2010, at The Hotel Hershey in Hershey, Pennsylvania.

Effective antiviral therapy is the only hope for survival or alleviation of disease for millions of Americans and tens of millions of individuals worldwide suffering from chronic viral infections, including those caused by HIV, HBV, HCV, and others. In addition, there is a continuing threat of global outbreaks from influenza, SARS, and other newly appearing or resurgent viruses. Despite considerable progress in the development of effective inhibitors that target specific aspects of viral life cycles, therapeutic efficacy has been limited by the evolution of resistant virus. This problem not only results in the failure of therapy, but may limit the effectiveness of subsequent therapies. Moreover, attempts to counter drug resistance lead to complex, expensive, and toxic regimens. Antiviral drug resistance is therefore of paramount importance in dealing with growing epidemics caused by virus infection.

The Symposium on Antiviral Drug Resistance: Targets and Mechanisms brings together researchers studying a variety of virus systems to exchange new information on viral targets for therapy, on antiviral drugs, and on drug resistance. We believe that understanding the similarities and differences in diverse viral systems will lead to new insights into the problem of resistance in each individual virus.

The focus of the Symposium is on specific molecular targets, their normal structure and function, their interactions with antiviral drugs, and the evolutionary basis and specific mechanisms of viral resistance. Organized by molecular target, the program will include invited speakers as well as oral and poster presentations selected from submitted abstracts. The covered topics include:

Biology of Viral Infection
Viral Entry
Nucleic Acid Replication
Integration
Novel Antiviral Strategies
Assembly, Release, and Processing

This Symposium is sponsored by the University of Pittsburgh and co-sponsored by the HIV Drug Resistance Program of the National Cancer Institute. Through the generous support of corporate sponsors, financial assistance is available to a limited number of postdoctoral fellows, students, and other non-physician researchers whose abstracts are selected for presentation but who are not in the position to support their own participation in the Symposium. If you are interested in applying for such financial assistance, click here for more information.

We hope you will join us in November for what promises to be a terrific 11th anniversary of this Symposium series.

John W. Mellors, M.D.
Division of Infectious Diseases
University of Pittsburgh

John M. Coffin, Ph.D.
Tufts University
(on contract to National Cancer Institute)

Stephen H. Hughes, Ph.D.
HIV Drug Resistance Program
National Cancer Institute

http://antiviralresistance.org

3–5 November 2010 International Conference on Antimicrobial Research (ICAR2010)

Valladolid (Spain)


ICAR will provide a new forum in Europe for the presentation, exchange and dissemination of information and experiences on anti-microbe strategies (against bacteria, fungi or protozoans), in biotic or abiotic environments, in planktonic or adhered states, in biologically specific or unspecific ways, in vitro or in vivo. "Anti” is here taken in a wide sense as “against cell cycle, adhesion, or communication”, when harmful for human health (infectious diseases, chemotherapy...) and/or industry/economy (food, biomedicine, agriculture, livestock, biotechnology, water systems...). It will include topics on antimicrobial resistance, (early) microbial and resistance detection, enhancement of innate defences against pathogens, as well as methods & techniques.

http://www.formatex.org/icar2010

14–17 October 2010 2010 ASBMS Annual Meeting

Snowbird Resort and Conference Center, Snowbird, UT, USA

Thematic Meetings and Symposia

Program at a Glance

GENOME DYNAMICS THEMATIC GROUP:

  • DNA Transactions
  • Chromatin and Transcription
  • Biological Chemistry of RNA
  • Protein Synthesis, Catalysis and Turnover

METABOLISM THEMATIC GROUP:

  • Lipid Interactions in Physiology and Disease
  • Metabolism and Disease
  • Hypertension: Treatment, Disparities and Molecular Mechanisms

CELL SYSTEMS THEMATIC GROUP:

  • New Frontiers in Genomics and Quantitative Proteomics
  • PSI-Structural Genomics, sponsored by NIGMS/NIH
  • Systems Biology, Synthetic Biology and Signal Transduction
  • Chemical Biology and Drug Discovery

SPECIAL INTERESTS:

  • Education and Professional Development Committee Sponsored: Careers in Biochemistry and Molecular Biology: A World of Options, A Variety of Skills
  • Minority Affairs Committee Sponsored: Mentoring
  • Public Affairs Symposium
  • American Cancer Society sponsored symposium: Research Funding by the American Cancer Society

http://www.asbmb.org/Meetings_01/2010mtg/2010mtghome.aspx

23–24 September 2010 Chromation Control of Viral Infection

Bethesda, Maryland, USA

The role of chromatin and epigenetic regulation in cellular transcription, replication, and development has been well recognized. However, it has only recently been appreciated that invading viral pathogens that depend upon cellular nuclear machinery are also subject to the regulatory impacts of chromatin.

For lytic pathogens, successful infection depends both upon the ability to counter cellular defense mechanisms, such as deposition of nucleosomes with repressive chromatin marks, as well as the ability to utilize cellular activities that install positive marks to promote the efficient utilization of cellular transcription and/or replication machinery. Additionally, viral pathogens whose complex replication cycles include coupled stages of lytic replication and latency/persistence are impacted by epigenetic regulation that plays a controlling role in determining the viral state.

Advances in understanding the basic biology of chromatin deposition, modification, and modulation/remodeling will contribute to the understanding of viral diseases and present novel opportunities for prophylaxis or treatment. The workshop "Chromatin Control of Viral Infection" brings together leaders in this research area, representing various viral families as well as select experts in general chromatin biology.

http://www.blsmeetings.net/ViralChromatin2010/index.cfm

11–16 September 2010 The XVth International Congress of Virology

Sapporo, Japan

National Organizing Committee

Chairperson:

  • Fusao Tomita

Vice-Chairperson:

  • Sumio Shinoda

Member:

  • Toshiya Hirayama
  • Toshihiro Horii
  • Tadayuki Imanaka
  • Aikichi Iwamoto
  • Fumiko Kasuga
  • Yuzuru Mikami
  • Masao Mitsuyama
  • Akio Nomoto

Secretary General:

  • Morimasa Yagisawa

http://www.congre.co.jp/iums2011sapporo/index.html

7–8 September 2010 1st International Workshop on XMRV: Pathogenesis, Clinical and Public Health Implications

Bethesda, MD, USA

The objective of this scientific conference is to assemble an international group of scientists, physicians, and epidemiologists to present and discuss, in a public forum, the latest XMRV studies on a range of topics including virus-host interactions, cell type tropism, mode of transmission, animal models, and the efficacy of current antiretroviral drugs. This meeting will offer an interactive setting where the latest developments in the field can be presented in order to evaluate the state of our knowledge, address controversies, and develop an understanding between experts that will help direct future research.

http://www.virology-education.com/index.cfm/t/1st_International_Workshop_on_XMRV/vid/1FF10297-0DC4-5841-64634A68A3EC3EF1

31 July–3 August 2010 1st World Congress of Virus and Infections

Busan, Korea

Dear Colleagues,

It is nice to announce that BIT\'s 1st World Congress of Virus and Infections (WCVI) will be held during July 31~August 3, 2010 in South Korea. In order to make an all round communication with experts world wide and strengthen the cooperation between each other, the Organizing Committee of WCVI 2010 cordially expects your participation to accelerate and promote the cognition of virology in the world!

The 1st World Congress of Virus and Infections, with a theme of Voice of Virologists, is actually the extension of the previous two annual World Summits of Antivirals. There are 3 parallel symposiums in 2010: 1st World Congress of Virus and Infections, 1st Annual Inaugurate Symposium of Hepatitis Virus and 3rd Annual World Summit of Antivirals . Thanks to the proposals and suggestions of our former distinguished participants, WCVI 2010 will set World Summit of Antivirals as the essence, arrange a unique symposium for hepatitis virus and enlarge its involvement in animal and plant antivirals.

The 2nd Annual World Summit (WSA-2009) has achieved great success and attracted over 270 delegates from more than 40 countries
( http://www.bitlifesciences.com/wsa2009 ). For the recent two years, enormous national heroes have made great contributions to this event, such as, the two Laureates-Dr. Harald zur Hausen and Dr. Luc Montagnier; Dr. Pierre Tiollais, from Institut Pasteur; the top leading organizations and corporations-WHO, IAPAC, CMBA, SAFEA, Roche, Pfizer, Novartis, GSK, Schering Plough, Merck, etc.

We are convinced WCVI 2010 will provide an ideal forum for the promotion of relevant companies, products and services among key decision makers all over the world. Your participation will enrich the meeting and advance our mission of empowering the innovations for virology fields! We sincerely hope you could participate and contribute your invaluable experience and knowledge at this magnificent conference for the development of the immense program!

We are strongly expecting your participation!

Sincerely Yours,

Xiaodan Mei
Executive Chair of WCVI-2010
President, BIT Life Sciences, Inc.

http://www.bitlifesciences.com/wcvi2010/default.asp

18–23 July 2010 18th International AIDS Conference - AIDS 2010

Vienna, Austria

AIDS 2010 will mark an important milestone: the deadline by which world leaders have committed to ensuring universal access to HIV prevention, treatment, care and support. The conference will be an opportunity to evaluate progress to date and to identify what must be done, both individually and collectively, to achieve this critical goal. With an estimated 25,000 participants and 2,500 media in attendance, the eyes of the world will be upon Vienna.

http://www.aids2010.org/

17–21 July 2010 The American Society for Virology 29th Annual Meeting (ASV 2010)

Montana State University, Bozeman, MT, USA

The American Society for Virology (ASV) was founded in 1981 to provide a forum for investigators of human, animal, insect, plant, fungal and bacterial viruses, whether the research involves the use of clinical, ecological, biological or biochemical approaches. The Society sponsors an annual meeting, designed to promote discussion and collaboration among scientists active in all aspects of virology.

http://www.asv2010.com/

21–25 June 2010 14th International Negative Strand Virus Meeting

Bruges, Belgium

In Bruges this scientific sessions will be held at the Concertgebouw. The posters and talks will review all recent developments in basic research on negative strand viruses, including progress in high resolution structure determination, the control of negative strand viral RNA synthesis, and the cellular innate response to negative strand virus infection etc.

http://sites.google.com/site/nsv2010mtg/home

21–25 June 2010 Viruses of Microbes

Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France

Given recent major discoveries in the domain of viruses infecting Archaea, Bacteria and unicellular Eukaryotes (Protists), we are convinced that a gathering of these different scientific communities would be a timely and productive endeavour for unifying the knowledge on different groups of viruses into a consistent picture, filling the gap that presently divides scientists working on prokaryotic and eukaryotic viruses and helping to form a cohesive view of the viral world.

This First International Congress on Virus of Microbes marks a new era in viral research, which has begun with the recognition that viruses are the predominant component of the biosphere numerically, with a considerable impact on the planet’s ecology, and represent the greatest genetic resource in the biosphere, significantly affecting biosystem’s evolution.

At the meeting will be highlighted global aspects of problems concerning the diversity, ecology, and environmental impact of viruses infecting Bacteria, Archaea and microbial Eukaryotes. Actively will be discussed also problems of the origin and nature of viruses, and their role in early life evolution.

Particular attention will also be given to technological and medical applications of microbial viruses, including their exploitation in “phage display” studies, their potential in developing new advanced materials for nanotechnology, and their medical application.

The topics considered at the congress will be covered in the following 5 scientific sessions:

  • Environment, Ecology, Diversity
  • Origin and Evolution
  • Genomics and Molecular Biology
  • Virus-Cell Interactions
  • Technological and Medical Applications

http://www.pasteur.fr/infosci/conf/VirusMicrobes2010/

7–10 June 2010 4th Annual Meeting EPIZONE

Saint Malo, France

At this Annual Meeting we discuss recent issues and new developments concerning epizootic animal diseases, stimulate cooperation and create vast opportunities for networking, scientific exchange and discussions. We shall provide a challenging scientific programme with plenary lectures by invited speakers and selected oral and poster presentations. All presentations will be related to recent research in epizootic diseases of cattle, swine, poultry, sheep, fish or horses in the fields of the EPIZONE themes diagnostics, vaccine development, risk assessment, surveillance and epidemiology.

\'Bridges to the Future\'

The slogan \'Bridges to the future\' relates to the ambition of EPIZONE to support the introduction of innovative, improved, fast, and acceptable control measures to combat animal diseases in relation with food safety and climate change. As platform and think-tank of highly qualified scientists EPIZONE develops new strategies and tools to face new challenges in the future and remains a solid Network of Excellence in the coming years.

We look forward to a stimulating 4th Annual Meeting and hope you join us in Saint Malo.

http://www.epizone-eu.net/annualmeeting/default.aspx

30 May–4 June 2010 ESF-EMBO Symposium - Antiviral Applications of RNA Interference

Hotel Eden Roc, Sant Feliu de Guixols, Spain

The second ESF-EMBO symposium on "Applications of antiviral RNA interference (RNAi)" will be held in the early summer of 2010 (May 30 – June 4, 2010) in Sant Feliu de Guixols at the Costa Brava in Spain. Some 100 participants are expected to come together from the fields of RNAi research and virology to present their latest findings on RNAi-virus interactions, as well as the progress in the development of RNAi-based antiviral therapeutics. One of the big questions that will be addressed concerns the role of RNAi in natural antiviral defence mechanisms in mammals. In addition, new solutions to improve the efficacy and safety of RNAi-based antiviral drugs will be presented. The combined expertise of researchers studying RNAi in plants, insects and mammalian systems is supposed to greatly stimulate the overall discussion.

http://www.esf.org/index.php?id=6439

23–26 May 2010 10th International Feline Retrovirus Research Symposium (IFRRS)

Charleston, South Carolina, USA

IFRRS is a bi-annual conference that focuses on the latest advances in genomics, immunology, and infectious disease as well as gene therapy, anti-viral therapy and vaccine development from the perspective of feline health and the potential translational applications to human health. The goal of the symposium is to provide a forum for participants to share cutting-edge data and ideas and to foster collaborative efforts to improve feline and human health.

The symposium attracts a diverse attendance from academia, industry, and clinical specialists. There is no other conference that brings together renowned experts from the international scientific community involved in retroviral research employing the feline model.

http://www.ifrrs.org/

28–29 April 2010 HCV Drug Discovery

Hilton San Diego Resort, San Diego, CA, USA

It is an exciting time for the field of HCV antivirals. Viral protease and polymerase inhibitors are in late stage clinical trials, as are combinations of them, suggesting an interferon-free drug cocktail to treat HCV may one day be possible. Progress is also being made on small molecule drug candidates that inhibit host proteins involved in the maturation/processing of HCV particles.

Join fellow drug discovery chemists for one and a half days of presentations, posters, roundtable and panel discussions plus plenty of networking time to stay abreast of this burgeoning area and hear the latest medicinal chemistry optimizations and clinical trial strategies and progress of small molecule drug candidates targeting HCV infection.

Topics Presented:

  • Protease Inhibitors
  • Non-nucleoside and Nucleoside Polymerase Inhibitors
  • Inhibiting Viral Structural Proteins
  • Targeting Cellular/Host Proteins
  • Combination Strategies

http://www.drugdiscoverychemistry.com/dch/hcv

7–11 April 2010 4th European Congress of Virology

Villa Erba Congress Centre, Cernobbio, Lake Como, Italy

The congress will be the annual meeting of the European Society for Clinical Virology, the German/Swiss/Austrian Society for Virology (Gesellschaft fϋr Virologie) and the Italian Society of Virology.

The Eurovirology Congresses, renamed European Virology Congresses, were initiated in 2000 to bring together young and senior investigators from all Countries of Europe and from all branches of Virology. The aim was to strengthen Virology in Europe, by providing a platform for basic, medical, clinical, veterinary, and plant Virology. Congresses were held sequentially in UK, Spain and Germany. Importantly, they have fostered the foundation of the European Society for Virology (www.eusv.eu), the inaugural meeting of which will be held in Rome, April 24, 2009.

The Venue is the beautiful Spazio Congressi Villa Erba, Cernobbio, Lake of Como. This is one of Italy's most enchanting corners. Cernobbio, very close to Como, dominates the west side of the lake and offers a breathtaking view of miles of the lake. Lake Como has always been and still is a world famous international resort. Visitors are enraptured by its charming atmosphere and natural beauty. Cernobbio-Como are 50 Km away from the Malpensa Airport, the main airport in Northern Italy.

http://www.eurovirology2010.org/

24–26 March 2010 16th ISHEID - HIV & Emerging Infectious Diseases

Parc Chanot, Congress Center, Marseille, France

The 16th ISHEID congress is an ideal opportunity to network and to increase and update your knowledge ! Come to Marseille from 24 to 26 March 2009 to listen to the renowned International Leaders in the fields of HIV and Hepatitis Viruses give you State-of-the-Art Lectures.

The 16th ISHEID congress is the major International Conference specifically designed by scientists to give specialists an opportunity to :

- receive high quality scientific information
- meet in a friendly atmosphere
- and give you practical information for everyday use

http://www.isheid.com/site/-10ISHEID,671-?lang=eng

21–26 March 2010 The Keystone Symposia Meeting on HIV Vaccines

Fairmont Banff Springs, Banff, Canada

Traditionally, the Keystone Joint HIV Symposia have integrated vaccines and pathogenesis to comprehensively cover the field—from HIV’s fundamental biology to its interaction with the human immune system and how to design a vaccine—and these Joint Symposia have been convened every year. In addition to this Keystone Joint Symposium, there are a couple of other well-established HIV vaccine meetings in the year (CROI and the AIDS Vaccine Conference) that follow a similar format and also often feature a similar line-up of speakers. Since an HIV vaccine is proving to be a particularly recalcitrant problem, a novel approach that facilitates a wider cross-fertilization of ideas would be very valuable and would be welcomed by the broader HIV vaccine research community. To that end, the major development proposed for the 2010 Keystone HIV Vaccine Symposium is to foster innovative ideas and new collaborations with immunology and vaccinology as it pertains to other viral diseases. Specifically, we propose that a new Joint Symposium of HIV Vaccines in conjunction with Viral Immunity be convened. This Joint Symposium would retain the valuable format that includes joint and separate sessions covering general and specific principles.

http://keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1051

21–26 March 2010 The Keystone Symposia Meeting on Viral Immunity

Fairmont Banff Springs, Banff, Canada

The most exciting recent advances in viral immunity include the increased understanding of the role of innate immune mechanisms, interaction between innate and adaptive immunity, pathogen manipulation of host responses, and activation of immune responses and generation of immune memory. Despite these advances, basic mechanisms of anti-viral immunity are poorly characterized particularly for chronic infections. Efforts are also required to exploit recent research advances to improve vaccine design and therapeutic intervention. This meeting will include both innate and adaptive immunity and juxtapose animal models with human studies as it attempts to foster collaborative efforts between attending viral immunologists and the HIV vaccine researchers in the joint meeting. Expert talks in plenary sessions will encompass the latest in critical areas of viral immunity. Workshops and additional presentations will cover provocative and cutting-edge results from attendees. The meeting objective is to accelerate progress in understanding and manipulating anti-viral immunity to improve human health.

http://keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1050

23–26 February 2010 EMBO World Lecture Course - VIRUS-HOST: partners in pathogenicity

San Jose, Costa Rica

The EMBO World Lecture Course will focus on recent progress made in examining the interplay between some well-studied plant and animal viruses and their hosts.

http://cwp.embo.org/wlc10-01/index.html

16–21 February 2010 The Keystone Symposia Meeting on Cell Biology of Virus Entry, Replication and Pathogenesis

Sagebrush Inn and Conference Center, Taos, NM, USA

The Keystone Symposia meeting on the Cell Biology of Virus Entry, Replication and Pathogenesis emphasizes key aspects of virus infection pathways and cellular responses. A central goal is the identification of critical virus-cell crosstalk during these processes. Rather than dividing viruses into separate “categories” such as positive-sense RNA viruses and DNA viruses, the meeting highlights common aspects of virus lifecycles among different virus groups. The multi-disciplinary nature of the proposed meeting is important in bringing together investigators using structural, molecular, cell biological, immunological and epidemiological methods. This emphasis on shared themes and multiple experimental approaches will continue to be critical to future advances in virology. While there has been spectacular recent progress in our understanding of virus lifecycles, we are still very far from being able to design antiviral strategies, and unexpected novel aspects of virus cell biology are constantly being discovered. Plenary sessions will cover the most important aspects of virus interactions with cells. Day 1 will include cutting-edge structural virology studies and imaging methods to follow single virus particles during entry. Day 2 will focus on the entry mechanisms of enveloped and non-enveloped viruses and the roles of cellular proteins in virus infection. Day 3 will cover viral and cellular aspects of virus replication and cellular antiviral responses. The last day will focus on the important areas of virus assembly and pathogenesis. Late-breaking exciting developments in this fast-moving field will be incorporated by short presentations and afternoon workshop sessions drawn from the submitted abstracts.

http://keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1049

12–17 January 2010 The Keystone Symposia Meeting on HIV Biology and Pathogenesis

Santa Fe Community Convention Center, Santa Fe, NM, USA

The Keystone Symposia Meeting on HIV Biology and Pathogenesis emphasizes key aspects of the basic virological, cell and molecular biological, and disease aspects of HIV. The focus will be to highlight recent advances in our understanding of HIV/AIDS ranging from the earliest events of transmission, to treatments for infected individuals, to interventions to prevent viral transmission. The goal of the meeting is to emphasize the basic mechanisms of viral replication and the interplay of the virus with the immune system leading to the development of AIDS.

http://keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1053

16–18 November 2009 11th International Hepatitis C Conference

Manchester, UK

The 11th International Hepatitis C Conference will be a three day event with a full programme of international speakers and oral abstract presentations. The conference will be held in the UK at the Lowry Hotel Manchester on the 16th-18th November 2009.

http://www.hepc09.org.uk/

15–18 November 2009 SADR2009: 10th Annual Symposium on Antiviral Drug Resistance

Wyndham Virginia Crossings Hotel and Conference Center, Glen Allen, Richmond, Virginia, USA

We are pleased to announce that the 10th Annual Symposium on Antiviral Drug Resistance: Targets and Mechanisms will be held November 15-18, 2009, at the Wyndham Virginia Crossings Hotel and Conference Center in Richmond, Virginia.

http://antiviralresistance.org/

20–25 October 2009 The Keystone Symposia Meeting on Overcoming the Crisis of TB and AIDS

Arusha International Conference Centre, Arusha, Tanzania

Tuberculosis (TB) is the largest cause of death in the AIDS setting, having caused approximately 50% of all AIDS deaths globally. Each infection on its own manipulates the host immune response to enhance the other infection’s pathogenicity, and the treatment of each involves long or lifelong therapy of complicated drug regimens. The focus of this Keystone Symposia meeting is to gain deeper insights into the immune pathology and deadly synergism between HIV and TB and its global toll in order to identify new ways to solve this global catastrophe by way of basic scientific discovery, and the development and delivery of vaccines, drugs and care. Mycobacterium tuberculosis survives in the vast majority of infected individuals without causing disease. However, as HIV compromises the immune system it fuels clinical emergence of TB and, as a result, has become the driving force for the current TB epidemics in Subsaharan Africa and Asia. TB in turn drives HIV-1 replication and causes HIV-1 disease progression. In order to effectively tackle this twin epidemic, integrated approaches encompassing basic immunological research, drug discovery, drug and vaccine design and delivery and novel approaches to delivering care in remote and impoverished areas must be integrated. This includes the following: virologic and bacteriologic research on the pathogens themselves; immunologic, molecular and cellular research on the host response; design, development and delivery of drugs and vaccines; development of different technologies for biomarkers of disease and cure; and novel drug and vaccine delivery systems. Moreover, basic discovery must be synergized with novel approaches to the delivery of TB and AIDS care in endemic areas. The overarching goal of the symposium is to gain a broad perspective on the problem of TB/AIDS – from its impact on life on earth to the basic biology of the organisms, the immune response – and to develop new paradigms of thinking and responses to deal with the humanitarian catastrophe of TB and AIDS co-infection.

http://keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1022

21–23 September 2009 Frontiers of Retrovirology

Montpellier, France

HIV affects 33 million individuals worldwide. To date, 25 million have died from AIDS. In 2007 alone, 2.7 million persons became newly infected with HIV-1, and 2 million new AIDS deaths were registered. A quarter century after the discovery of the HIV-1 virus, a curative or a vaccine strategy for AIDS remains elusive. This conference will bring together leading human retrovirus researchers to review current progress and to chart future challenges. Internationally renowned speakers will present their insights into the principles guiding the life cycle of endogenous retroelements, complex human retroviruses, and their pathogenic interactions with the hosts.

http://www.amiando.com/frontiersofretrovirology.html

11–15 July 2009 American Society for Virology Annual Conference 2009

University of British Columbia, Vancouver, Canada

The American Society for Virology invites you to participate in the 28th Annual Meeting being held at the picturesque Vancouver campus of the University of British Columbia. The 2009 ASV scientific program will include symposia and concurrent sessions on multiple aspects of virology.

http://www.asv2009.com/

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top